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ABSTRACT OF THE DISSERTATION 
OUTCOMES OF TRANSITION TO ADULT HIV CARE 
 IN PERINATALLY HIV-INFECTED YOUNG ADULTS 
by 
Susan Biersteker  
Florida International University, 2016 
Miami, Florida 
Professor Consuelo Beck-Sagué, Major Professor 
Transitioned perinatally HIV-infected patients may be at increased risk for poor 
outcomes, yet the impact of transition and of transition programs on health are not well 
understood. This research examined: (1) post-transition mortality, (2) engagement in 
adult HIV care, (3) transition experiences, and clinical and sociodemographic influences, 
including transition program exposure.  
Data were collected from patients who had transitioned from a Florida pediatric 
clinic to adult HIV care between January 2003 and September 2012.  Post-transition 
mortality and care engagement were assessed in a retrospective analysis of medical 
record data. Fisher exact and Kruskal-Wallis tests were used for significance testing. Risk 
ratios (RRs) were calculated to assess strength of associations. Stratified analysis 
controlled for confounding. Transition experiences were examined in a mixed-methods 
study, with qualitative data from a computer-assisted survey subjected to thematic 
analysis.  
Of 51 transitioned patients, nine (18%) had died by May 2014, five (56%) in the 
first post-transition year. Of 42 survivors, 33 were eligible; 27 (82%) provided consent.  
v 
 
Post-transition mortality was high, particularly in those severely immunosuppressed 
(CD4 count <100/mm3; RR =6.0, 95% CI =1.88-19.19 [P=.005]) at transition. When 
controlled for CD4 count, employment was associated with decreased (adjusted RR= 
0.19; 95% CI=0.04-0.88 [P=.02]), and high school non-completion with increased 
(adjusted RR= 3.0; 95% CI=1.37-6.40 [P=.07]) mortality risk. The number of kept HIV 
appointments decreased from last pre-transition (Median = 5, IQR 4-6) to first post-
transition (Median = 2, IQR 1-10; P=.002) year; the proportion of poorly engaged 
increased from 3% to 35% (P=.006), with no significant changes between first and 
second post-transition years. Non-Hispanic black and low-income participants were less 
likely to be regularly engaged in adult HIV care one year post-transition. Transition 
program exposure did not significantly affect mortality or care engagement. Most of 27 
received transition services, but 59% had trouble doing well in adult care. Needs for 
patient-centered care, with caring, personal patient-provider relationships and accessible 
HIV care, characterized post-transition experiences.  
This research suggested that transitioned perinatally HIV-infected young adults 
are at risk for poor health outcomes. Systematic programs using a socio-ecological 
framework to include multi-level interventions and post-transition support may improve 
outcomes. 
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CHAPTER I 
INTRODUCTION 
Epidemiological Changes in Perinatal HIV Cases  
Medical advances since the mid-1990s greatly improved the life expectancy of 
children infected with HIV early in life.1,2  With widespread access to combination 
antiretroviral therapy (cART) -especially in industrialized or developed countries- many 
perinatally HIV-infected (PHIV) children who were expected to die in early childhood, 
now survive into adolescence, young adulthood and beyond.3 Simultaneously, effective 
interventions to prevent mother-to-child transmission, including cART therapies, 
significantly reduced the number of children born with HIV.  Without interventions, 
perinatal transmission rates are estimated at 18% to 32%.4 Currently, transmission rates 
in the United States (US) are 1-2%; national policies aim for a reduction to <1%, which is 
regarded as feasible if sufficient and adequate resources are employed to deliver all 
recommended interventions to prevent mother-to-child transmission.5   
In the US, the pediatric HIV population1 consists of a relatively stable group of 
approximately 10,000 infected children, adolescents, and young adults, with the addition 
of less than 100 new cases annually.6,7 As a consequence of epidemiologic trends, most 
US PHIV children are now adolescents and young adults.6-8  Significant racial/ethnic 
health disparities exist in PHIV, as demonstrated in the state of Florida. Black infants 
accounted for 75% of the pediatric HIV cases reported through 2012, while only 21% of 
the Florida population is Black.9 Like most HIV-infected heterosexual women and men, 
                                                          
1 Pediatric cases include children infected with HIV prior to age 13; 95% of pediatric cases are perinatally-
acquired HIV.   
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most PHIV children are poor and live in urban, impoverished neighborhoods, where HIV 
prevalence is 20 times greater than among US heterosexuals overall.10,11 
New Challenges in HIV Treatment and Care 
Long term survival of PHIV children poses new care and treatment challenges. 
The growing cohort of adolescents and young adults with PHIV requires lifelong 
treatment to control for viral replication, prevent immune deterioration and transmission 
of HIV.12  They were infected before development of their immune systems, and most are 
significantly treatment experienced, often with suboptimal mono- and dual antiretroviral 
regimens before more effective triple regimens became available.7,13,14 Many PHIV 
adolescents and young adults will be in advanced stages of HIV disease and have 
complex medical histories, complicating treatment and limiting therapy options.15 As 
more PHIV children grew older, high risks of treatment failure and antiretroviral 
resistance, and long term complications of lifetime HIV disease, including metabolic 
disorders and neurocognitive impairment, became evident.12,13  With effective cART, 
AIDS dementia and encephalopathy have almost disappeared in the United States, but 
concerns regarding more subtle central nervous system and learning disabilities have 
emerged.13,16 Higher rates of psychiatric symptoms, particularly attention deficit-disorder 
and depression, were reported in HIV infected youth compared to uninfected youth from 
similar socioeconomic backgrounds.17 Explanatory, multifactorial, causes include 
biological (e.g. HIV-associated neurocognitive disorder) factors, treatment complications, 
including disfiguring adverse effects (e.g. lipodystrophy), and psychosocial factors, 
including living with a chronic illness, loss of parents, and HIV/AIDS stigma.  
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With the transformation of HIV from a fatal to a chronic disease, the goal of HIV 
care has shifted toward achieving long-term optimal health outcomes through consistent 
ART adherence and responses. Continuous care is essential for all people with HIV-
infection, as even short lapses in HIV care may have significant consequences for viral 
suppression, drug resistance, and HIV transmissibility.18 As PHIV children mature, they 
may be less likely to adhere to HIV appointment schedules and ART regimens, compared 
to younger children and HIV-infected adults. While retaining HIV-infected patients in 
medical care at regular intervals results in better health outcomes,19 studies reported 
prolonged poor engagement in adult HIV care extending from adolescence through 
young adulthood.20  Viral suppression can be achieved with adherence levels of 54% - 
100% to newer, more potent non-nucleoside reverse transcriptase and boosted protease 
inhibitor containing cART regimens.21 Nevertheless, perfect adherence remains an 
important goal; self-reported adherence among HIV-infected youth was reported between 
40%-84%, and tends to be lower than in adults.12   
Long-term survival of youth also comes with unanticipated needs in reproductive 
health, higher education, and employment.13 Growing autonomy and independence, 
formation of intimate relationships, and management of education and employment may 
be difficult for all adolescents. These issues may be particularly challenging for PHIV 
adolescents as they have to be managed in the context of HIV disease and care, 
HIV/AIDS stigma, and economic and social stress.22    
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Transition from Pediatric to Adult Care  
Long-term survival is also accompanied by the need for a “seamless” health care 
transition from pediatric or adolescent services to adult HIV care settings to ensure 
continuous HIV care. Most US pediatric or adolescent clinics follow their patients up to 
age 24-25 years, after which patient care has to be transferred to adult HIV providers. 
With the ‘coming of age’ of the largest cohort of PHIV children (infected between early 
1980’s and late 1990’s), more patients than ever before will transfer from pediatric or 
adolescent services to adult care in the next decade.23 Transition from pediatric and 
adolescent clinical services to adult care is widely regarded to be challenging, largely 
because of fundamental differences between pediatric and adult HIV care models.22,24 
Most pediatric and adolescent clinics have long-established relationships with their 
patients, and offer comprehensive ‘one-stop’ services in a familiar and nurturing 
environment. In contrast, adult clinical services tend to be less accommodating and more 
impersonal, and require patients to self-manage their HIV disease and independently 
navigate fragmented adult health care systems. PHIV young adults may not have the 
functional autonomy presumed in adult HIV care.25  As PHIV children in the US 
disproportionally belong to poor racial or ethnic minority communities, psychosocial 
issues, including living in impoverished neighborhoods, poverty, and HIV/AIDS stigma, 
may further complicate successful transition.11 These issues may be exacerbated by the 
complexity of the US healthcare system, and the under-resourced and stressed system of 
HIV care for patients who depend on public health insurance.26,27  
Recognizing the risks associated with poor health care transition, with 
transitioned PHIV young adults becoming sub optimally engaged in adult HIV care or 
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being lost to care, successful transition has become a key aspect in maintaining the health 
of PHIV adolescents and young adults.8,28 Consequently, transition programs and services 
to prepare patients for a ‘smooth’ transition have become a key component of pediatric or 
adolescent care.  
Literature Review: Transition from Pediatric/Adolescent to Adult HIV Care 
 Transition of medical care is not simply an administrative procedure. It refers to 
the purposeful, planned preparation of adolescents and young adults with chronic 
physical and medical conditions, their families, and their caregivers to successfully 
transfer from comprehensive, child-centered, care to adult-oriented care.29 Successful 
transition requires autonomy in all realms of life, including taking personal control over 
health issues, coming to terms with sexual orientation, and planning of future educational 
and vocational goals.23   
Health care transition first evolved as a concept of care several decades ago, when 
prognosis improved for children diagnosed with other pediatric conditions than HIV, 
including cancer, cystic fibrosis and type 1 diabetes.30  In 1984, US Surgeon C. Everett 
Koop hosted the first national conference “Youth with Disability: The Transition Years,” 
to describe emerging needs and transition challenges.31 Five years later, the Surgeon 
General’s conference entitled “Growing Up and Getting Medical Care: Youth with 
Special Health Care Needs,” developed the first national agenda to develop specific 
strategies and action steps to establish a seamless health care transition from  child-
centered to adult-centered medical services.31  In the following years, the Society of 
Adolescent Medicine,29 US Department of Health and Human Services, 28 Academy of 
Pediatrics,8 and others professional organizations published transition recommendations 
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and guidelines. Despite these efforts, modest progress has been made. There still is an  
urgent need for coordinated, integrated and evidence-based transition services and 
programs for adolescents and young adults with chronic diseases.22,32  
PHIV young adults, due to their more recent improvement in survival, have been 
relatively understudied. To date, the transition literature has focused on understanding 
issues young people with HIV face as they “age out” of pediatric or adolescent care. 
‘State-of-the-Art’ review articles concluded that most studies utilized qualitative research 
methods to explore anticipated transition barriers from the perspectives of youth who still 
had to transition, their caregivers and providers.24,33,34  Across various studies, transition 
is considered to be challenging because of  the loss of longstanding, familiar relationships 
with pediatric providers, anxieties about increased responsibility for disease management 
and presumed medical independence in adult HIV care.35-40  Logistical challenges, 
including medical insurance and access to medical and social services, may further 
complicate transition.  
Similar barriers were first discussed at the first national conferences on needs of 
children with chronic diseases in the 1980s, and were commonly described in following 
studies of young adults with chronic diseases.30,31,41,42 Transitioning adolescents and 
young adults with chronic diseases share the burden of lifetime disease management and, 
therefore, may face comparable transition barriers. However, unique challenges including 
HIV/AIDS stigma and discrimination, disclosure-related issues, and the risk of secondary 
transmission, may further complicate transition of young adults with HIV2.44   HIV/AIDS 
                                                          
2 Young adults with HIV includes youth with perinatally and behaviorally acquired HIV-infection. 
Although the course of infection differs, transition challenges and outcomes may be similar.8,43 
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is also different from some other chronic diseases as it disproportionally impacts socially 
and economically marginalized populations.11 Racial and ethnic disparities in transition 
success are relatively unexamined. Some evidence from studies of youth with chronic 
diseases indicated that youth from racial and ethnic minorities received less adequate 
transition preparation, while low-income youth were found to be at higher risk of 
experiencing gaps in access to care as they aged into adulthood compared to their 
counterparts with higher incomes.27  Qualitative studies of young adults with HIV 
suggested that adverse social conditions may be barriers to successful transition, 
including lack of transportation and stable housing, unemployment, food insecurity, and 
problems obtaining and accessing health insurance.11,25,37     
The paucity of transition outcome data and the lack of evidence-based transition 
programs are widely recognized as the most important gaps in the transition literature.33  
Concerns about poor transition outcomes of PHIV young adults were primarily based on 
anecdotal information of pediatric providers, and on findings of studies of youth with 
chronic diseases other than HIV disease. These studies showed poorer outpatient clinic 
attendance, poorer adherence to medications, and increased morbidity and mortality after 
transition to adult clinical care.38  However, little is known about clinical outcomes of 
transitioned PHIV young adults, as few pediatric or adolescent clinics track their patients 
after they leave their care.13,37 Post-transition mortality has been assessed in England and 
Ireland. This retrospective study reported a relatively - compared to adults with HIV- 
high mortality rate (4%) in a cohort of transitioned PHIV adolescents and young adults.45  
A study conducted in the US reported a non-significant downward trend in immune status 
(self-reported CD4+ T-lymphocyte [CD4] count) in a cohort of US transitioned PHIV 
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young adults.38  A recent retrospective study of transitioned patients with behavioral and 
perinatally-acquired HIV concluded that the health care transition process needs to be 
optimized as only 50% of patients were retained in adult HIV care one year post-
transition, and had completed at least two clinical visits 43 Additionally, cross-sectional 
studies suggested that health may decline after transition to adult HIV care. Poorer 
clinical outcomes were documented in patients seen in adult HIV care compared to their 
peers in pediatric care,46,47 and HIV-infected adult patients. 48 Recent studies reported 
prolonged poor engagement in adult HIV care extending from adolescence through 
young adulthood (25-34 years old).20 Loss-to-follow-up was found to be associated with 
receiving care at adult clinical settings.49  
Acknowledging the risk of poor transition outcomes, transition services and 
programs became a key component of pediatric or adolescent care.8,28   Many US  
pediatric or adolescent HIV clinics have developed and implemented transition programs 
and services for HIV-infected youth.37 In the tradition of chronic diseases, self-
management became the central focus of transition programs for adolescents and young 
adults with HIV.  For example, in the policy statement “Transitioning HIV-infected youth 
into adult health care” of the American Academy of Pediatrics (2013), it was stated that  
“Seamless and successful transition from pediatric to adult-oriented care is 
dependent on these youth acquiring skills to allow them to be responsible for their 
management of their own health care. A well-planned transition enables youth to 
optimize their ability to assume adult roles and responsibilities.” 8(p193)  
Although the importance of transition preparations and programs for transition 
success of PHIV young adults is widely supported, there is no high quality evidence 
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available to inform policies and programs. Strategies and clinical recommendations for 
successful transitioning, including development of formal transition plans, assurance of 
transition readiness, optimizing communication between adolescent and adult clinics, 
educational, employment and life-skills training, were proposed, but it’s not clear how 
effective these interventions are in improving health outcomes.8,28  Likewise, workbooks 
by the National Resource Centers of the AIDS Education and Training Centers to assist 
providers to prepare their patients for transition were developed, but - to our knowledge - 
not evaluated.24  In addition, of the few published protocols or models for HIV specific 
health care transition, only one (pilot) evaluation of the “Movin’ Out” for behaviorally 
HIV-infected young adults was published.50   
Evidence-based transition models may be unavailable because transition of HIV-
infected young adults is a relatively new phenomenon.37  However, despite the fact that 
the concept of health care transition was developed decades ago, little high quality 
evaluation of transition programs for youth with chronic diseases has been 
published.30,51,52 Methodological issues, including lack of well-defined outcome 
indicators, poorly described interventions, problems in including comparisons groups and 
measuring separate effects of comprehensive interventions, and a lack of dedicated 
funding for program development, implementation and evaluation are considered to be  
major barriers to the development of evidence-based transition programs.51  
Statement of the Problem 
As the prognosis for HIV disease has improved, an increasing number of PHIV 
children are living well into adulthood.53 With the “coming of age” of the largest cohort 
of PHIV children, more young adults than ever before will transition from pediatric or 
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adolescent services to adult clinical care in the next decade.23 Management of HIV 
disease in medically and socially vulnerable PHIV adolescents and young adults is 
challenging, and requires lifelong treatment and excellent medication adherence to 
achieve viral suppression, and prevent deterioration of immunologic status and secondary 
transmission.12  
Largely because of system differences between pediatric and adult HIV care 
settings, transition may be associated with poor health outcomes with potentially negative 
consequences for both personal and public health.8 Because of the risk of poor transition 
outcomes, with PHIV young adults becoming sub optimally engaged in adult HIV care or 
being lost to follow-up, transition programs to prepare adolescents and young adults for a 
smooth, successful, transition became a key component of pediatric or adolescent care.   
However, transitioning of PHIV young adults is a new phenomenon who remain 
understudied. Studies examining outcomes of transition and effects of HIV-specific 
transition programs are needed to establish theory- and evidence-based programs to support 
transitioning young adults.  This study addresses gaps in the transition literature by 
assessing health outcomes and the effect of a transition program for PHIV young adults 
who transitioned from a pediatric outpatient HIV clinic in South Florida.  Clinic staff 
wanted to know: (1) How their transitioned patients were doing post-transition; (2) If the 
transition program had helped their patients to transition, and (3) What improvements to 
the transition program were needed.   
Study Context: Pediatric Clinic in South Florida 
 This study was initiated on request of the Infectious Diseases & Immunology 
pediatric clinic, University of Miami, located in Miami, Florida. Florida is among the 
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states with the highest HIV/AIDS prevalence and HIV incidence in the nation, with the 
highest HIV/AIDS burden in South Florida.54 Through 2013, Florida ranked second (only 
to New York State) in the number of pediatric AIDS cases.55  
The pediatric clinic is a partner of the Miami Family Care Program, which was 
one of the 13 original Pediatric AIDS Health Care Demonstration Projects in 1988, and 
has been funded through the Health Resources and Services Administration’s (HRSA) 
Ryan White Part D program since incorporation in the Ryan White Care Act in 1994. The 
clinic provides out-patient, multi-disciplinary, and family-based healthcare services to 
low-income and underserved children, adolescents, and young adults up to 25 years in 
age who acquired HIV early in life, nearly all through vertical transmission. Currently, 
most of the approximately 160 patients are adolescents or young adults.  Funding for 
supportive or ancillary services is largely unavailable in the adjacent adult public 
hospital, with about 2,700 adult HIV-infected patients, to where most pediatric patients 
have transitioned. Consequently, transitioned young adults do not receive the support and 
assistance to which they were accustomed in comprehensive pediatric HIV care, 
including but not limited to: follow-up in case of missed appointments, counseling and 
home delivery services to support medication adherence, and assistance with housing, 
transportation and completion of insurance paper work.  
Study Context: Comprehensive Transition Program 
Since 2008, the pediatric clinic has received funding to implement a 
comprehensive transition program to address concerns about high attrition rates and non-
adherence to medical appointments and medication regimens after patients transitioned to 
adult HIV care. The transition program aimed to facilitate a smooth transition (Figure 1). 
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It was assumed that, in order to maintain health post-transition, patients should be able to 
independently navigate adult HIV care and attend regularly scheduled HIV appointments, 
adhere to medication regimens, and access case management and supportive services.   
 
Figure 1. Conceptual model of the transition program 
The causal chain from determinants to program methods and interventions was 
not included in a program plan, in itself a major weakness. Discussions with program 
planners a posteriori, and subsequent literature review to describe theoretical 
underpinnings, provided the following information on how the program was expected to 
cause changes and impact transition outcomes. Health care transition is considered to be a 
vocational needs of patients as they move from pediatric to adult care settings.29  
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Ad 1. Social Determinants.   In theories of social production of disease (or social 
determinants), distribution and access to key health-promoting factors (including: 
education, income, a safe environment, influence and power) are regarded as more 
critical to attainment of health than individual knowledge, attitudes and behaviors.56  
According to these theories, patients who completed high school, were employed and 
stably housed would have better prospects for transition. As described in Figure 1, 
transition program interventions included neurocognitive testing to advise educational 
strategies, vocational support, help to access housing and financial aid, in 
acknowledgement of the impact of social and economic conditions on the risk on illness, 
and on the actions people take to prevent or treat their illness. Examples in Box 1 
illustrate postulated links between social determinants and health. These examples not 
only clarify possible associations between social determinants and patient’s health and 
transition success, but also identify potential program limitations. As interventions are 
restricted to individual-level interventions, the social context (including the quality of 
education, social services and other neighborhood characteristics, as well as education, 
labor and social policies), which may impact patients’ health is largely beyond the 
transition program focus and not modifiable through the program’s interventions.  
Ad 2: Lack of Continuity between Pediatric and Adult HIV Care.   Pediatric and 
adult HIV care have been described as “two different worlds.”44 To support patients to 
overcome logistic transition barriers, pediatric staff discussed an individual transition 
plan with patients, provided referrals to adult HIV physicians and social service 
organizations, and transferred patient medical records to the referred physician. If needed, 
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pediatric staff would accompany patients to their first appointment. A pediatric social 
worker was available to provide support to access services in the first post-transition year. 
 
Ad 3.  Lack of Self-management Skills. The change from HIV as an acute condition  
rapidly progressing to mortality to a chronic condition has brought emphasis to the 
importance of self-management, with patients assuming an active and informed role in 
managing physical, psychological, and social aspects of health.64  Because pediatric 
providers may treat their patients protectively and expect a lower level of autonomy of their 
patients compared to adult providers, interventions to improve self-management of HIV 
disease are assumed to be essential to prepare pediatric patients for the requirements of 
adult HIV care.8,35 This vision corresponds with the developmental  transition model  that 
recognizes the changing needs of  patients for autonomy and the lessened role of family 
members or guardian when patients mature.32 Mechanisms to which positive effects of self-
management could be attributed is most likely self-efficacy, rather than acquisition of    
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knowledge or specific skills.65 Self-efficacy, or the context specific self-confidence that 
one can perform required behavior, is the central concept of the self-management theory 
and stems from the social-cognitive theory developed by Albert Bandura.66  Common 
elements of self-management programs include tasks in the domain of physical health 
(including treatment adherence and accessing appropriate treatment and services), 
psychological functioning (including:  empowerment and reducing negative emotions), and 
social relationships (including: collaborative relationships with providers, social support, 
and disclosure).64   
 Self-management programs are systematically planned and goal-oriented. 
Although the pediatric clinic’s transition program did not include a systematic plan, 
interventions including life skills and support groups, and the transition clinic are based 
on the self-management model. Thematic “life-skills” groups were held periodically to 
prepare patients for independence. Topics ranged from household skills to medication 
adherence, seeking employment, and completion of insurance paperwork. Regular 
support groups were offered to help patients deal with social and emotional aspects of 
HIV disease.  The transition clinic was developed to ‘bridge the gap’ between pediatric 
and adult medical HIV care.67 In the year before they transitioned, patients were seen for 
routine appointments by an adult provider at the pediatric clinic (pre-transition clinic) to 
establish rapport and alleviate anxieties. Subsequently, patients were seen by the same 
adult provider at the transition clinic (post-transition clinic) located at the adult clinic site, 
for up to one year.  A pediatric social worker provided support services during the first 
post-transition year. In the second year post-transition, the patient was assumed to be 
well-established in adult care and able to navigate services independently. The transition 
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clinic and follow-up services temporarily facilitated required behavior and were  sources 
of self-efficacy to teach patients to solve their problems, including performance 
mastering (overcoming obstacles through experience); modelling of expected adult 
provider-patient interaction, and social persuasion (including: appraisals from the 
pediatric social worker during follow-up).65  
Interventions to enable patients to establish a relationship with their future adult 
provider pre-transition are based on communication theories. A trusting and respectful 
physician-patient relationship is considered to be critical to health management, although 
systemic and social barriers may interfere.68 Physician-patient communication 
characterized by effective exchange of information and positive affect may lead to greater 
patient trust (proximate outcome) and to greater adherence to treatment recommendations 
(intermediate outcome), which may lead to positive health outcomes.69 Patients were 
invited to meet the adult provider pre-transition to build a trusting relationship and 
alleviate their anxieties to break ties with familiar and trusted pediatric providers, but 
specific interventions to achieve affective and effective physician-patient communication 
were not developed.   
Study Aims and Hypotheses 
This study was conducted to answer four major questions:  
1. What were the health outcomes and experiences of transitioned PHIV young 
adults?  
2. Were clinical, socioeconomic, and psychosocial vulnerabilities pre-transition 
associated with adverse health outcomes post-transition? 
3. Did the transition program affect transition outcomes?  
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4. How can the transition program be improved?  
To answer these questions, three study aims were formulated and accompanying 
hypotheses were tested. In this dissertation, each study aim corresponds to a chapter.  
Aim 1   To assess post-transition mortality and associated clinical and sociodemographic  
  factors, including exposure to the transition program. 
1.1  H0 Survival does not differ by pre-transition clinical and sociodemographic  
                         patient characteristics.  
Halt      Poor health status (low CD4 count and/or high quantitative HIV RNA 
plasma levels), socioeconomic vulnerability (including: poverty, low 
educational attainment, unemployment, and reliance on public medical 
insurance), or psychosocial vulnerability (including: maternal vital status, 
and patient relationship status) at time of transition are associated with 
post-transition death.  
1.2   H0 There are no differences in survival by transition program exposure. 
Halt Transition program exposure decreases mortality risk.  
Aim 2  To assess post-transition engagement in adult HIV care and associated clinical 
and socio-demographic factors, including exposure to the transition program.  
2.1      H0  No change in engagement in HIV care post-transition.   
Halt  Engagement in HIV care decreases post-transition.  
2.2  H0  Engagement in adult HIV care is not associated with clinical,  
             sociodemographic, or psychosocial patient characteristics.  
Halt  Adverse factors at time of transition, including poor health status (low 
CD4 count and/or high quantitative HIV RNA plasma levels), poor 
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medical appointment keeping, socioeconomic vulnerability (including: 
poverty, low educational attainment, unemployment, and reliance on 
public medical insurance), or psychosocial vulnerability (including: 
maternal vital status and patients’ relationship status) are associated with 
poor engagement in adult HIV care post-transition.   
2.3   H0  Exposure to transition program activities is not associated with  
engagement in HIV care post-transition.  
             Halt     Patients who were exposed to the transition program are more likely to  
be engaged in adult HIV care compared to unexposed patients.  
Aim 3  To describe participants’ satisfaction with the transition program, and assess their 
pre-and post-transition experiences in order to develop program recommendations 
and contribute to the development of effective, theory- and evidence-based 
transition programs.      
3.1  Did participants successfully transition? Are they currently regularly engaged in 
adult HIV care and able to access needed services?  How is their health?  
3.2 How did participants experience transitioning to adult HIV care? What has helped 
them to transition?   
3.3  What were their post-transition experiences? What were their experiences in adult 
HIV care?  Did they have difficulties with accessing medical and social services, 
obtaining medical insurance or experience adherence or health-related problems?  
3.4 Based on their experiences, what are their recommendations for improvement of 
the transition program?  
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CHAPTER II 
STUDY DESIGN AND METHODOLOGY 
Applied Research 
This research was conducted on request of the staff of a pediatric clinic to provide 
follow up information on their transitioned patients to inform future program activities 
(Attachment 1). Pediatric clinic staff was involved in all study phases. Participation is not 
only a fundamental characteristic of health promotion, but also allows the inclusion of 
views of informed stakeholders; increases understanding and acceptance of the findings, 
and promotes commitment to act on study findings.1   
Study Design 
A single-center, retrospective cohort study was conducted to assess the health 
outcomes mortality (Aim 1) and engagement in HIV care (Aim 2), and associated 
sociodemographic and clinical factors, including exposure to transition program 
activities.  Information was obtained from participants’ medical and social records. To 
assist in the interpretation of these quantitative findings and formulation of transition 
program recommendations, transition experiences and experiences in adult HIV care 
were explored in a mixed-methods explanatory concurrent research design.2  Quantitative 
and qualitative data were obtained from a computer-assisted survey and short debriefing 
interview (Aim 3).  
Study Population and Procedures 
Study approval was obtained from the Institutional Review Boards of Florida 
International University (IRB-14-0298, most recently on October 19, 2015), and 
University of Miami (IRB- 20120433, closure on March 30, 2015) [Attachments 2-3]. 
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Patients were eligible for study participation if they had transitioned from the Infectious 
Diseases & Immunology pediatric clinic, University of Miami, to adult medical HIV care 
settings between January 2003 and September 2012.  Living patients were excluded from 
study participation if they were unable to provide valid informed consent in person 
because of severe cognitive disability (as determined by staff psychologists during 
routine testing while in pediatric HIV care), incarceration, or relocation. Patients received 
care at the pediatric clinic up to age 25; all transitioned patients eligible for study 
participation were adults.  
Patients who had died post-transition were included.  Different recruitment 
methods were used to enroll living eligible patients, because transition experiences and 
outcomes of patients who successfully transitioned may differ from those who did not.3 
Many patients had stayed in contact with the pediatric clinic or with their peers after they 
transitioned. They were contacted in person or by phone by the pediatric program 
coordinator to introduce the study. The study lead author followed up to provide 
additional study information to patients who were interested to participate and set up an 
appointment. If up-to-date contact information was unavailable, we asked study 
participants to inform their peers about the study. In addition, pediatric clinic staff was 
asked to tell former patients about the study, if they contacted the clinic or stopped by. 
Per protocol, eligible participants were marked as “refused” if they did not respond to 
three attempts to contact them, or if they did respond and declined participation. “Loss to 
follow-up” was assigned when current contact information could not be obtained.   
Patients willing to participate provided written informed consent (Attachment 4), 
and signed HIPAA (Authorization to Use and Disclose Health Information) and 
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Authorization of Health Information for 3rd Party Disclosures forms at the pediatric clinic 
site. To further protect the privacy of research participants, a confidentiality certificate 
from the Department of Health & Human Services was requested and received 
(Attachment 5). To enable the patient to make a voluntary and informed decision, consent 
was obtained by a researcher who had not been involved in previous care. The consent 
form was written in as simple terms as possible, and all patients were able to read and 
understand English (per information of the pediatric clinic Ryan White Part D 
coordinator).  Even so, the researcher read and discussed the consent form with 
participants to ensure comprehension.   
Study recruitment began in September 2013 and was completed in February 2014.  
Review of medical and social records was completed on April 30, 2014. Study 
participants received $20 in cash and reimbursement or validation for parking and travel 
costs. Participants were offered support from pediatric staff to access adult medical or 
social services, if needed and desired.  
Data Collection 
Data to examine post-transition mortality (Aim 1) and engagement in HIV care 
(Aim 2) and associated factors were abstracted from participant’s medical and social 
records. Data were recorded on a standardized, de-identified, chart abstraction form 
(Attachment 6). To asses if measures were clear and unambiguous and to be collected 
information was available in existing data sources, the data collection instrument was 
pre-tested using medical records of two deceased patients. Information was abstracted 
from medical and social paper records (before 2010) and electronic records (UChart for 
medical and CAREWare for sociodemographic information) thereafter.  Specified post-
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transition clinical information of participants who transitioned outside of the University 
Medical Center was requested by fax, accompanied by signed HIPAA (Authorization to 
Use and Disclose Health Information) and Authorization of Health Information for 3rd 
Party Disclosures forms.  
Data to assess participants’ (post)-transition experiences (Aim 3) were collected 
with a computer-assisted survey (Qualtrics), administered at the pediatric clinic.  The 
survey was followed by a de-briefing to allow participants to clarify or elaborate on their 
answers. To improve quality, the survey instrument was pre-tested among six clinic 
patients with PHIV who had transitioned less than one year ago, and, therefore, were not 
eligible for study participation. Pre-test was conducted to examine if: (1) questions were 
clear and understood as intended (validity), (2) participant burden was acceptable, and (3) 
participants’ were at ease with the mode of survey administration.  In general, 
participants felt the survey was easy to understand and complete, asked the right 
questions, and was not too long. A review of pre-test data showed participants needed on 
average 24 minutes to complete the survey; all participants completed all questions, and 
no inconsistent answers were observed. Nevertheless, in de-briefing to retrieve 
participants’ reasoning processes using cognitive probes (e.g. “In your own words, what 
do you think we wanted to know”, and “How did you decide to choose this answer”), it 
became apparent that some questions needed to be revised.4 In addition, while the initial 
survey had few open-ended questions to minimize participant burden, pre-test 
participants requested to add more open-ended questions, to - as one participant worded- 
“Have our voices heard.”  The revised questionnaire was administered to participants.  
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Measures 
 Measures to test study hypotheses of Aim 1 (Mortality) and Aim 2 (Engagement in 
HIV care) are presented in Figure 2.   Outcome variables differ; co-variates are the same. 
Subsequently, quantitative and qualitative measures to assess transition experiences and 
program recommendations (Aim 3) will be described.   
 
Figure 2. Co-variates study aims 1 (assess post-transition mortality) & 2 (engagement in HIV care) 
Outcome Variables Study Aims 1 & 2 
Aim 1: To assess post-transition mortality. Primary outcome: death after transition. 
Patient status was marked on a transition log, which was kept and updated by pediatric 
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staff. Participant status was marked as deceased if patients had died before April 30, 2014, 
when data collection was completed.   
Aim 2: To assess engagement in pediatric and adult HIV care.  Primary outcome:  
engagement in HIV care, defined as kept appointments with an HIV provider.  
Engagement in HIV primary care is increasingly recognized as a crucial step in 
maximizing patient outcomes.5 Participants’ last medical visit at the pediatric clinic was 
recorded as the transition date. For patients who had dropped out of pediatric care, the 
administrative transition date was their 24th birthday. For all participants, the number and 
dates (m/y) of kept visits were abstracted for at least two observation periods: 12 months 
before the patient’s transition date, and 12 months post-transition. Depending on patient 
status and transition duration, we also captured the number of medical visits in the second 
year post-transition.  
A recent study comparing six different retention measures concluded that there is 
no clear “gold standard” and advised to use multiple retention measurements.6 We 
measured engagement in HIV care as: (1) the number of kept visits during a 12-month 
observation period, and (2) visit constancy: proportions of participants attending at least 
one primary care visit at 3-month [quarterly] intervals in a 12-month [four quarters] 
observation period. We measured visit constancy, because retaining HIV-infected 
patients in care at regular intervals results in better health outcomes.7 The 3-month 
interval is based on pediatric clinic practices where patients were scheduled to see their 
HIV provider quarterly for a routine appointment, consistent with national 
recommendations. 
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Co-variates 
Patient characteristics. Information regarding patient characteristics, including 
patient gender, race ethnicity, transmission category, transition date, and transition age 
was abstracted from participants’ pediatric medical and social records.  Racial, ethnic 
(Black or African American, White, non-Hispanic or Hispanic) and birth country data 
(US born or not) were collected because disparities were documented in risk of mortality 
in HIV-infected persons in Florida 8,9 and engagement in HIV care.10 Participants’ gender 
was recorded because of reported gender disparities in health care utilization and 
medication adherence.10,11   Standardized information about patients’ mental health 
status, substance abuse, and medication adherence was not available. Patient records did 
include physician’s observations regarding these factors for some patients, which were 
reported for deceased patients only.    
Primary care history included markers of progression of HIV disease (CD4+ T-
lymphocyte [CD4] count and quantitative HIV RNA plasma levels [“viral loads”]).  For 
all participants, CD4 count and viral load were abstracted for 2 periods: pre-transition 
(most recent test results when participants transitioned and left pediatric care), and one-
year post transition. For participants who had transitioned two years or more ago, we also 
abstracted two-year post transition information, as well as their most current information 
e.g. most recent available test results). Frequency of hospital admissions in the year 
before participants’ transition date were also recorded.  
Social and economic factors. Social and economic factors included educational 
attainment, household income, housing, employment status, and type of health insurance.  
The most recent information at participant’s transition date was recorded. Educational 
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attainment measured the highest level of education completed at time of transition, and 
included the following categories: did not complete high school; high school or 
equivalent; vocational/tech program after high school; college or university (some) or 
unknown. The equivalent of obtaining a high school diploma was successfully passing 
the General Education Development (GED) test; a terminal degree for those with 
interrupted academic trajectories because of health or other problems.12 Employment at 
transition assessed whether participants were (un)employed and/or enrolled in school; 
more detailed information regarding type of employment, job security, if participants 
worked full or part-time and other work-related characteristics that may impact health 
were unavailable.  Household income was abstracted using the following categories: 
equal or below federal poverty level (FPL); 101-200% of FPL; 201-300% of FPL; 301-
400% of FPL; ≥ 401 of FPL, and unknown. Participants with a recorded household 
income equal to or below the federal poverty level ($23,850 for a four-person US 
household in 2014) were considered to live in poverty.13 Housing - in the last 12 months 
pre-transition, most of the time- was measured using six categories, including homeless 
(in the street, outdoors or shelter), moved around, lived in own or shared placed, with 
(extended family), other (please explain), and unknown. Finally, enrollment in health 
insurance (yes/no) when participants transitioned to adult HIV care was assessed in 
different categories, measuring whether participants had obtained private or public 
(Medicaid or Medicare) medical insurance or relied on Ryan White funding to cover their 
healthcare costs.  
Psychosocial factors. Psycho-social factors which may impact participants’ health 
status included participant relationship status at time of transition (including: married, in 
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relationship, but not married, single or unknown) and maternal vital status. Information 
was obtained from the Ryan White Part D coordinator.  
Exposure to the comprehensive transition program. To measure exposure to 
transition program activities, the following information was abstracted: (1) participants’ 
transition date before 2008 or thereafter, when the comprehensive transition program was 
funded and implemented, and (2) attendance of the transition clinic (including: pre- 
and/or post-transition clinic).  Information about exposure of individual participants to 
specific components of the transition program was incomplete. Therefore, with exception 
of transition clinic attendance, the potential value of single program components could 
not be assessed.  
Transition Experiences and Program Recommendations (Aim 3) 
Social-demographic and clinical measures. Social-demographic information, 
including age, gender, race/ethnicity, educational level, household income below or 
above poverty level [$24,250 for a four-person household in 2015],14 and transition date 
were abstracted from participant’s pediatric records. To assess current circumstances, we 
asked participants to answer questions about housing, family, and (any) employment 
status, as well as gaps in medical insurance in the past 12 months.  A measure of food 
insecurity, “In the past year, were you ever worried whether food would run out before 
you got money to buy more?” was used as a proxy measurement of current poverty.15 
Data to describe engagement in adult HIV care were abstracted from the patient adult 
medical records. Based on current HIV/AIDS performance measures, the expectation for 
medical HIV care was at least one medical visit in a 6-month period in the past 12 
months.16   
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Participant experiences and program recommendations.  This study incorporated 
questions of a semi-structured transition telephone survey by Wiener and colleagues, 
developed to describe transition barriers, as identified in earlier studies.17 Because this 
study administered a computer-assisted survey to collect study data, we were able to ask 
additional, more detailed (close- and open ended) questions.  Figure 3 presents the 
questions to assess participant’s exposure to and satisfaction with the transition program, 
their experiences with transitioning and post-transition experiences, and their suggestions 
for improvement of the transition program.  After survey completion, the lead researcher 
invited participants to clarify or elaborate on their survey answers in a short de-briefing 
interview. Participant quotes were written down verbatim; observational notes were 
completed directly after the interview.  
Statistical Analysis 
Analysis of quantitative data was performed using Epi Info 3.5.4 (Atlanta, GA, 
2012).  Univariate statistics (means, standard deviation [SD], medians, interquartile range 
[IQR], and mode) were used to describe characteristics of the study population. 
Continuous data (e.g. CD4+ T-lymphocyte [CD4] count and quantitative HIV RNA 
plasma levels [“viral loads”]) were analyzed using the Kruskal-Wallis test for two groups 
(alpha=0.05), which has no assumption of normal data distribution. Outcome variables 
(e.g. mortality [Aim 1] and engagement in HIV care [Aim2]) and covariates were 
dichotomized for inferential statistical analysis.  The Fisher exact two-tail test 
(alpha=0.05) was used to assess whether differences in categorical variables were 
statistically significant. Risk ratios (RRs), as measures of relative risk, were calculated to 
assess the strength of associations between potential predictors and primary outcome 
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variables; 95% confidence intervals (CIs) were calculated to assess precision of RRs. 
Stratified analyses were conducted to control for confounding and assess effect 
modification, using Mantel-Haenszel (MH) RRs and 95% CIs and Fisher exact tests to 
compare differences across strata for statistical significance.   
 
Figure 3. Survey questions to assess transition experiences and suggestions for transition program 
improvements 
Qualitative information (Aim 3) included participant’s responses to open-ended 
questions of the computer-assisted survey and participant’s verbatim quotes from a short 
de-briefing interview. This information was systematically analyzed using the thematic 
analysis method.18  Thematic analysis is an iterative process followed to remain true to 
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participant’s description while developing more abstract concepts in various stages of 
data analysis.  Analysis was conducted manually, and included the following steps: 
familiarization with data and repeatedly reading texts, generating initial codes, grouping 
codes in different themes, and refinement and consideration of the meaning within and 
across themes. In the final, exploratory phase, the analysis was discussed with a third 
researcher to explore associations between core concepts and themes, established 
literature, and theoretical perspectives related to transition experiences of PHIV young 
adults.  To minimize pre-conceived notions and potentially expand (alternative) 
explanations, we conducted multiple coding by two different researchers. Both 
researchers had HIV-related research experience, but not with PHIV adolescents or 
young adults. To further minimize the risk of researcher bias and furnish alternate 
interpretations, a third researcher, who had former clinical and research experience with 
PHIV adolescents and young adults but had not been involved in the study design or data 
collection, reviewed the analytic framework and data interpretation.   
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What’s Known on This Subject  
Transition from pediatric to adult care of perinatally HIV-infected young adults may 
impact health, but post-transition mortality and associated factors have not been assessed 
in North America.   
What This Study Adds  
When stratified by other factors, severe immunodeficiency, high school non-completion 
and unemployment at time of transition were independently associated with mortality; 
transition clinic attendance did not affect mortality.  
ABSTRACT 
Objective: To describe mortality in perinatally HIV-infected young adults after transition 
to adult care and identify associated factors. 
Methods: Patients who had transitioned from a pediatric outpatient clinic to adult HIV 
care between January 2003 and September 2012 were recruited for a retrospective cohort 
study, completed on April 30, 2014. The main study outcome was post-transition death. 
The most recent clinical and social-demographic data before transition were abstracted 
from medical and social records.  
Results:  Of 51 transitioned patients, nine (18%) had died, all of HIV-related causes, 
most (5 [56%]) in the first year post-transition. Of 42 survivors, 33 were eligible; 27 
(82%) provided consent. Immunosuppression (CD4+ T-lymphocyte [CD4] count <100 
cells per μL) at transition was associated with a six-fold higher risk of mortality (67% vs. 
11% in patients with CD4 count >100 cells perμL; relative risk [RR] =6.0, 95% CI=1.88-
19.19 [P=.005]). When controlled for CD4 count, employment at time of transition was 
associated with an almost 80% reduction in mortality risk (MH adjusted RR= 0.19; 95% 
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CI=0.04-0.88 [P=.02]), and GED/high school non-completion with three times higher 
risk of death (MH adjusted RR= 2.97; 95% CI=1.37-6.40 [P=.07]).  All patients who died 
(9) had a viral load > 1000 copies/ml; all deaths occurred in patients who had CD4 count 
<100 cells per μL (6) or lived in poverty (3). When controlled for CD4 count and poverty, 
mortality was identical among transition clinic attenders and non-attenders.  
Conclusions: Transition was associated with high mortality, particularly in patients who 
were severely immunosuppressed, unemployed or less educated at time of transition. 
Comprehensive programs should focus on improvements in clinical care and include 
academic and employment services.  
INTRODUCTION 
Mortality in perinatally HIV-infected (PHIV) children has declined considerably 
since the introduction of combination antiretroviral therapy (cART) during the late 
1990’s.1,2 In the United States (US), the pediatric HIV population consists of a relatively 
stable group3 of approximately 10,000 infected children, adolescents, and young adults, 
with the addition of < 100 newly infected infants born annually.4 Most children who have 
access to cART now survive into adulthood, “age out” of pediatric care, and transition to 
adult medical care.5  
A successful transition is regarded as a key aspect in maintaining health in this 
population.6,7  Recent State-of -the-Art articles describe a shared concern that transition 
may have adverse health effects, because vulnerable young PHIV adults will need to 
navigate the adult care system independently after leaving behind the familiar 
surroundings and comprehensive services available in most pediatric care settings.8,9 To 
date, however, little is known about clinical outcomes of PHIV young adults as few 
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pediatric or adolescent clinics track their patients after transition.10-12 As far as we know, 
post-transition mortality has been assessed in England and Ireland, but not yet in the 
United States.13 
There is a critical need to follow-up on transitioned PHIV adults to ensure that 
therapeutic successes of earlier decades continue to benefit them and to contribute to 
evidence-based transition practices, which may support young adults who will soon 
transition.14 The purpose of our study was to describe post-transition mortality and 
identify clinical and socio-demographic factors, including attendance at a transition clinic 
to facilitate adjustment to adult care, which may affect the risk of death after transition to 
adult HIV care, in a US cohort of PHIV young adults.   
METHODS 
Study Design   
We conducted a single-center, retrospective cohort study consisting of analysis of 
data of patients who transitioned to adult medical care from a university-based pediatric 
clinic in Florida in the Southeastern US. The clinic provides comprehensive HIV services 
to children, adolescents, and young adults up to age 24 who acquired HIV early in life, 
nearly all through vertical transmission. The clinic’s family-centered, comprehensive 
HIV services include case management, nursing, nutrition, neurodevelopmental 
assessment, mental health, and peer education and support, and is largely funded by the 
US Health Resources and Services Administration Ryan White Part D grant programs. 
Study approval was obtained from the authors’ ‘parent institutions’ institutional review 
boards.  
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Selection and Recruitment of Participants 
Patients were eligible for study participation if they had transitioned from the 
pediatric clinic to adult care between January 2003 and September 2012. Records of 
known deceased patients were reviewed. Living patients were excluded from study 
participation if they were unable to provide valid informed consent for clinical record 
review due to:  (a) severe cognitive disability, as was previously determined by staff 
psychologists in pediatric HIV care, (b) incarceration, or (c) relocation. Most transitioned 
patients had stayed in contact with pediatric clinic staff or with each other and were 
recruited by telephone or in person. Informed consent was obtained by a research staff 
member who had not been involved in previous care. All living participants were able to 
read and understand English, were older than 18 years of age, and had signed informed 
consent and Health Insurance Portability and Accountability Act (HIPAA) patient forms 
at the clinic site before collection of de-identified data. Participants who were not 
receiving medical care or other needed services were offered support by pediatric clinic 
staff to access services. Study participants received $20 and were reimbursed for travel 
and parking costs. Participant enrollment started in September 2013 and was completed 
in March 2014.  Data collection was completed on April 30, 2014.  
Data Collection and Measures 
The main outcome was death after transition, confirmed by medical record review 
or information recorded by the pediatric clinic coordinator.  Clinical, laboratory, and 
sociodemographic information included the most recent information available before 
transition to adult medical care. Researchers reviewed decedent and living study 
participants’ pediatric clinic medical and psychosocial services records to abstract the 
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following information on a de-identified standardized form:  primary care history 
(transition date, age at transition); demographic characteristics (birth year, gender, age at 
transition, HIV transmission category, race/ethnicity, foreign birth, educational 
attainment, housing status, household income, employment status, and type of health 
insurance), and psychosocial resources (relationship and family status). Racial, ethnic and 
birthplace data were collected because striking disparities by these factors have been 
documented in risk of mortality in HIV-infected persons in Florida.15,16 Abstracted 
sociodemographic information was reviewed and validated by the pediatric clinic 
coordinator.  Clinical information included markers of progression of HIV disease and 
response to ART (CD4+ T-lymphocyte [CD4] counts and quantitative HIV RNA plasma 
levels [“viral loads”].  Primary care history data included exposure to the comprehensive 
transition program (transitioned before 2008 or later when a formal transition program 
was implemented), and attendance of the pre- or post-transition clinic (see below). 
Objective, standardized, measures of ART adherence and substance use were 
unavailable; comments in progress notes were selected to describe clinician’s 
impressions.  
Transition Program 
In 2008, a formal comprehensive transition program was funded and implemented 
to address high attrition rates and to prepare patients for successful transition to adult 
HIV care. Program components included services to prepare patients for independent 
living (including educational and vocational support), increase self-management skills 
(including “life skills” and support groups), and “bridge” pediatric and adult HIV care 
(including discussion of transition plans, provision of linkages to adult services, and 
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availability of a transition clinic). Pediatric patients, primarily those who may have 
needed additional transition support, were referred to the transition clinic by pediatric 
staff.  In the last year pre-transition, patients were seen by an adult physician for at least 
one routine appointment at the pediatric clinic (pre-transition clinic).17 In the first year 
post-transition, patients were seen by the same adult physician, with whom they had 
started to build a relationship and who had more time allotted for a routine visit, in the 
adult HIV clinic of the nearby public hospital (post-transition clinic).  For one year post-
transition, support was also provided by the pediatric transition social worker.  
Statistical Analysis  
Analysis was performed using Epi Info 3.5.4 (Atlanta, GA, 2012). Univariate 
statistics (means, standard deviation [SD], medians, interquartile ranges and proportions) 
were used to describe characteristics of the study population. Continuous data were 
analyzed using the Kruskal-Wallis test for two groups (alpha=0.05), which has no 
assumption of normal data distribution. Covariates were dichotomized for inferential 
statistical analysis. The Fisher exact two-tail test (alpha=0.05) was used to determine 
whether differences in categorical variables were statistically significant. Risk ratios 
(RRs), as measures of relative risk, were calculated to assess the strength of associations 
between potential predictors and mortality, and 95% confidence intervals (CIs) were 
calculated to assess precision of RRs. Stratified analyses were conducted to control for 
confounding and assess effect modification, using Mantel-Haenszel (MH) RRs and 95% 
CIs and Fisher exact tests to compare differences across strata for statistical significance.    
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RESULTS 
A total of 51 patients transitioned from the pediatric clinic to adult medical care 
between January 2003 and September 2012. Nine (18%) had died by April 30, 2014, 
when data collection was completed. All had died of HIV-related causes. Five (56%) 
patients died within a year of their last pediatric clinic visit.  Median survival time among 
decedents was 195 days (range 13-2142 days).  None of the nine decedents were virally 
suppressed at time of transition and all had adherence issues (Table 3.1). Of the surviving 
42 patients, nine were excluded from recruitment for consenting because of severe 
cognitive impairment (3), incarceration (1), or residence outside of the county and 
inability to come to the clinic to provide informed consent (5). Of the 33 eligible to 
consent to medical record review, one was lost to follow-up, five declined participation, 
and 27 (82%) consented. The total study population for this analysis consisted of 36 
transitioned patients of whom nine had died since their transition to adult care.  
 Study participants were African-American/Haitian (83%) or Hispanic (17%) 
(Table 3.2). Only 17% were foreign-born. Almost half (47%) lived in poverty with 
household incomes equal to or below the federal poverty level ($23,850 for a four-person 
US household in 2014).18 Most were known to have been infected by vertical 
transmission (94%); one participant was infected by transfusion in the perinatal period 
and one by sexual abuse.  Most participants transitioned to adult HIV care at age 24; in 
2008 or later when a formal comprehensive transition program was funded and 
implemented. Pre-transition CD4 count were less than 200 cells/μL in almost half (47%) 
of the study population; median CD4 count was 381cells/μL,  and was lower for males 
(144; range 7-722 cells/μL) than females (386; range 12-831 cells/μL ; P=.06). Similarly, 
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median viral load in males (16,708; range 40-4,870,720 copies/ml) was higher than in 
females (318; range 28-500,000 copies/ml; P=.09). 
Risk of post-transition mortality did not differ significantly by gender, race, 
ethnicity or foreign birth (Table 3.3). Household income, type of health insurance, 
whether s/he was in a relationship and if his/her mother was deceased were also not 
associated with a significantly different risk of mortality. Mortality risk was somewhat 
lower among participants who transitioned before 2008 (when no formal transition 
support program was available), and was almost twice as high among those who ever had 
attended the transition clinic, although neither of these differences achieved statistical 
significance. Those who had severe immunosuppression (CD4 count <100 cells/μL, viral 
loads >1000 copies/ml) pre-transition were significantly more likely to have died. Pre-
transition viral loads were higher in decedents (median=83,800 copies/ml; IQR=15,416-
238,581 copies/ml) than in survivors (median=328 copies/ml; IQR=127-18,000 
copies/ml; P<.001). Conversely, employment was associated with a significant reduction 
in mortality. Completion of high school/General Educational Development test (GED) 
requirements was also associated with a reduction of mortality risk.  
Stratified analysis controlling for CD4 count affected the strength of associations 
between non-completion of high school/GED and mortality and employment and 
mortality (Supplemental Table 3.4). Low CD4 counts (<100 cells/μL) confounded the 
association between employment and mortality, weakening somewhat the protective 
effect of employment. When controlled for CD4 count, employment at time of transition 
was associated with almost 80% reduction in mortality risk (MH adjusted RR= 0.19; 95% 
CI=0.0-0.9, P=.02); GED/high school non-completion was associated with three times 
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higher risk of death (MH adjusted RR= 2.97; 95% CI=1.4-6.4, P=.07).  Patients living in 
poverty (income below FPL) or who had CD4 counts <100 cells per μL were more likely 
to die than others; all decedents had either a CD4 count < 100/ µl (6) or household 
income below poverty level (3). All nine deaths occurred in the 21 (43%) who had CD4 
counts <100 cells or lived in severe poverty (vs. 0 of 15 patients neither living in poverty 
nor severely immunosuppressed [0%]; P=.006).  Participants with these characteristics 
were also more likely to have attended the transition clinic (14/21 [67%] vs. 5/15 [33%]; 
RR=2.0; 95%CI=.92-4.4, P=.10). When the analysis was confined to participants who 
had a CD4 count <100 cells/μL and who lived in poverty, risk of death was identical in 
transition clinic attenders and non-attenders [42.9%].  
DISCUSSION 
These data suggest a very high post-transition risk of mortality; of 51 patients 
who transitioned between January 2003 and September 2012, nine (18%) patients died 
after transition, most within one year, all of HIV-related causes. In the study population 
(36 participants of whom nine decedents and 27 who were eligible and consenting), 
factors significantly associated with mortality were advanced immunosuppression, poor 
viral suppression, unemployment, and high school/GED non-completion at time of 
transition.  Most participants were US-born African-Americans or Haitians, reflecting the 
striking health disparities in perinatal HIV transmission in the United States.19 Social 
disadvantages were evidenced by the high proportion of patients living in poverty and 
who relied on Medicaid or Ryan White insurance for their health care costs. Transition 
clinic participation seemed to have been preferentially recommended to patients living in 
extreme poverty or with severe immunosuppression; when controlled for these factors, 
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mortality risk was identical among transition clinic attenders and non-attenders, 
suggesting that this intervention did not impact mortality.  
At transition, 25 out of 36 (69%) participants had CD4 counts <500 cells/μL, 
which was not unexpected as the young adults in our study acquired HIV before the 
development of their immune system, and before highly effective treatment became 
available in the late1990s; many PHIV patients have complex clinical histories and 
possibly HIV antiretroviral drug-resistant virus, complicating their care and limiting the 
choice of therapy.1,5,14  Treatment may have been further complicated by cognitive, 
developmental, and psychosocial challenges exacerbating difficulties adhering to lifelong 
therapies.20 
Several studies have documented poor health outcomes among HIV-infected 
adolescents and young adults in adult HIV care.12,21,22 As far as we know, only one study 
conducted in England and Ireland (United Kingdom [UK]) assessed mortality after 
transition to adult care.13 That audit of 14 adult clinics caring for 248 transitioned PHIV 
reported 11 deaths (4%) between September 2003 and March 2011, with seven deaths 
directly related to HIV-progression.  Compared to our study in a similar time period, UK 
patients transitioned at an earlier age (median 17 versus 23 years in our cohort), were less 
likely to die (11/248 [4%] versus 9/51[18%]), and had a longer post-transition survival 
time. The increased post-transition survival in UK PHIV adolescents and young adults 
may suggest a bias towards earlier death among our participants due to the longer 
duration of life with HIV infection at time of transition. Differences between health 
systems and social policies suggest additional explanations: the UK reports far superior 
retention in HIV care and viral suppression,23 while outcomes are particularly poor in 
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Florida for African-Americans and Hispanics.15,16 US patients on public insurance may 
be vulnerable to gaps in health insurance,24 whereas the UK National Health Service 
covers all citizens and is comparatively easier to navigate.25 Differences in social services 
expenditures also may be of importance in explaining differential health outcomes. 
Expenditures on social services, including housing, employment training, unemployment 
benefits and family support which have been found to be associated with improved 
outcomes, are proportionally higher in the UK, whereas the US allocates most health 
resources to health care.26   
The impact of social determinants on health is well documented.27,28  In our study, 
GED/high school non-completion and unemployment were associated with post-
transition mortality, particularly in patients who were not severely immunosuppressed. 
Lower educational attainment has been found to be associated with increased mortality, 
with substantial benefits of high school completion, especially for US African-
Americans.29  Several studies have shown associations between employment status and 
health among HIV-infected people.30,31  In our study, however, employment may also 
have been partially a marker for health, despite its independence of immune status. With 
few exceptions, studies show that “the lower an individual’s socioeconomic position the 
worse their health.” 27 p.1153 Study findings suggested that poverty impacted mortality, 
although the small sample size precluded definite conclusions.     
Our study is a preliminary exploration of mortality and associated factors among 
transitioned PHIV. One of the strengths of this study is the long duration of follow-up. 
Limitations include the small sample size and reduced power to detect statistically 
significant differences despite large effect sizes, ineligibility or non-participation of 15 
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living patients, and the retrospective nature of our study. We could not entirely discard 
the possibility that employment and education were markers of levels of health or social 
disorganization. Because of the poor health status of deceased patients at transition, it is 
unclear whether transition itself had negatively impacted the disease course. Because our 
study was conducted at a single site, generalizability of study findings may be limited.    
Despite these limitations, our study supports American Academy of Pediatrics 
guidelines suggesting that transition planning start early in adolescence and should ensure 
comprehensive care addressing physical health, and social, psychological, educational, 
and vocational needs.6 As PHIV youth mature, they encounter daunting challenges in 
managing their HIV disease while obtaining education and employment.  Comprehensive 
services should support youth to complete high school, obtain employment, and escape 
poverty. Clearly, transition of young adults who are severely immunosuppressed requires 
extreme caution; it may be prudent to provide ample resources to enable pediatric clinics 
to provide intensive support to improve patients’ immune status and viral responses to 
antiretroviral therapy before transition. Finally, in Florida, where mortality among adult 
African-American and Hispanic HIV patients is considerably higher than in White 
counterparts and mortality elsewhere in the United States, supportive, comprehensive, 
family-centered coordinated care typical of pediatric clinics should be considered even 
for adults instead of prioritizing preparation of pediatric patients to adjust to the less 
supportive services of adult care.32 
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Table 3.1. Characteristics of perinatally HIV-infected young adults at transition who died post-transition. 
 # Gender Race/Ethnicity Transition  
year  
Transition 
age  
(years) 
CD4 
count 
(cells/µl)  
Viral load  
(copies/ml) 
Hospital  
Admissions  
12 months  
pre-
transition 
(days/times) 
Survival 
time  
(days) 
Pediatric clinical 
notes 
1 female Haitian 2004 18 143 83,800 unavailable 2,142 “Unwilling to take 
meds. Does not 
want to discuss it.” 
2 female Hispanic 2007 19 12 500,000 63 (6) 152 “Multi-drug use.” 
“Extremely non-
compliant.” 
3 male Haitian 2008 23 <20 33,400 5 (1) 1,167 “Does not keep his 
appointments.” 
4 female African-American 2010 24 157 1,613 12 (2) 1,614 “Could not 
understand viral 
loads and explain 
it.” 
5 female African-American 2010 22 157 210,812 86 (13) 83 “Multi-drug use.” 
“Does not keep 
appointments.” 
6 male African-American 2011 23 <20 15,416 49 (5) 13 “Huge compliance 
issues.” 
7 male African-American 2012 23 <20 4,870,720 142 (15) 195 “Chronic non-
compliance.” 
8 male African-American 2012 23 <20 11,437 15 (2) 180 “Patient is not 
motivated to get any 
treatment.” 
 male Haitian 2012 24 <20 238,581 32 (3) 413 “Does not believe 
he has the virus.” 
“Huge resentment 
toward mother.” 
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Table 3.2. Sociodemographic and clinical characteristics at time of transition (N=36) 
Characteristic 
 
Overall 
 (n/%) 
Female          18 (50) 
Race/Ethnicity 
      African American 
      Haitian 
      Hispanic 
 
18 (50) 
12 (33) 
  6 (17) 
Foreign born        6 (17) 
HIV transmission route 
      Mother-to-child 
      Blood products 
      Sexual (abuse) 
 
34 (94) 
  1 (3) 
  1 (3)  
Mother deceased 30 (83) 
Married/in relationship  15 (42) 
Completed high school/GED 29 (81) 
Employment (full or part-time) 20 (56) 
Housing 
      Unstable 
      With (extended) family 
      Own or shared  
 
  2 (6) 
18 (50) 
16 (44) 
Household income 
       Equal or below Federal  Poverty Level (FPL) 
       101-200% FPL 
       201-400% FPL 
 
17 (47) 
12 (33) 
  7 (20) 
Health Insurance 
       Medicaid 
       Ryan White 
       Medicare 
       Private 
       No insurance  
 
25 (69) 
  7 (19) 
  1 (3) 
  2 (6) 
  1 (3) 
Age (years) at transition 
      Mean: 
      Median 
      Mode 
 
23  (SD1.7) 
23 (18-26) 
24 
Transitioned in or after 2008 26 (72) 
Attended Transition Clinic 19 (53) 
CD4+  T-lymphocyte count (cells/L)  
      <100 
       100-<200 
      200-499 
      ≥ 500 
 
 9  (25) 
 8  (22) 
 8  (22) 
11 (31) 
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Table 3.3. Factors associated with death (n=9) after transition to adult care (N=36) 
Characteristics at time of 
transition 
Died  
# (/%) 
Total Risk ratio  
(95% C.I.) 
P value  ͣ
Gender 
Male 
Female 
 
5 (28) 
4 (22) 
 
18 
18 
 
1.25 (0.40,3.91) 
 
 >0.99 
Race 
African-American or Haitian 
Hispanic 
 
8 (27) 
1 (17) 
 
30 
6 
 
1.6 (0.24, 10.54) 
 
>0.99 
Birth Country 
Foreign-born 
US-born 
 
1 (17) 
8 (27) 
 
6 
30 
 
0.63 (0.09,4.12) 
 
>0.99 
Relationship status 
Married/in relationship 
Single 
 
4 (27) 
5 (24) 
 
15 
21 
 
1.12 (0.36,3.49) 
 
>0.99 
Educational attainment 
Less than High School/GED  
High school/GED 
 
4 (57) 
5 (17) 
 
7 
29 
 
3.31 (1.19,9.22) 
 
0.10 
 
Employment status 
Employed 
Unemployed 
 
1 (5) 
8 (50) 
 
20 
16 
 
0.1 (0.01,0.72) 
 
.006** 
Household income  
Below Federal Poverty Level 
At or above Federal Poverty Level 
 
6 (35)  
3 (16) 
 
17 
19 
 
2.2 (0.66,7.58) 
 
0.34 
Medicaid status 
Medicaid insured 
Not Medicaid insured 
 
8 (32) 
1 (9) 
 
25 
11 
 
3.5 (0.50,24.84) 
 
0.30 
Maternal vital status 
Mother deceased 
Mother alive 
 
6 (20) 
3 (50) 
 
30 
6 
 
0.4 (0.14,1.17) 
 
0.30 
Transition time period 
Before 2008 
In or after 2008 
 
2 (20) 
7 (27) 
 
10 
26 
 
0.7 (0.18,2.99) 
 
>0.99 
Transition clinic attendance 
Attended transition clinic 
Did not attend transition clinic 
 
6 (32) 
3 (18) 
 
19 
17 
 
1.8 (0.53.6.07) 
 
0.56 
Viral load  
>1000 copies/ml 
≤1000 copies/ml 
 
9 (43) 
0 
 
21 
15 
 
----- 
 
.006** 
CD4+ T-lymphocyte count category 
<100 cells/μL 
≥100 cells/μL  
 
6 (67) 
3 (11) 
 
9 
27 
 
6.0 (1.88,19.19) 
 
 
.005** 
ͣ Fisher exact two-tailed test  
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Supplemental Tables 3.4. Characteristics at transition associated with death post-
transition, controlled for: a.) CD4+ T-lymphocyte count <100 cells per 𝛍𝐋 and b.) 
CD4+ T-lymphocyte count <100 cells per 𝛍𝐋 and living in poverty 
a.) CD4+ T-lymphocyte count < 100 cells per 𝛍𝐋 
Characteristic Number who Died (%) Relative Risk 
(95% CI)* 
P-value† 
Employed 1/3 (33.3) .40 .45 
Unemployed  5/6 (83.3) (.08-2.06)  
CD4+ T-lymphocyte count > 100 cells per 𝛍𝐋 
Characteristic Number who Died (%) Relative Risk 
(95% CI)* 
P-value† 
Employed 0/17 (0) 0 .08 
Unemployed  3/10 (30) ----  
 Adjusted 
Mantel-Haenszel   
Relative Risk 
(95% CI)* 
P-value† 
.19 .02 
(.04-.88)  
           
CD4+ T-lymphocyte count < 100 cells per 𝛍𝐋 
Characteristic Number who Died (%) Relative Risk 
(95% CI)* 
P-value† 
High School non-
completer 
2/2 (0) 1.8 .83 
High School graduate 4/7 (57.1) (.92-3.32)  
 
CD4+ T-lymphocyte count > 100 cells per 𝛍𝐋 
ART Number who Died (%) Relative Risk 
(95% CI)* 
P-value† 
High School non-
completer 
2/5 (40) 8.8 
 
    .16 
High School graduate 1/22 (4.5) (.98-79.05)  
 Adjusted 
Mantel-Haenszel   
Relative Risk 
(95% CI)* 
P-value† 
2.97 .07 
(1.37-6.40)  
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b) CD4+ T-lymphocyte count < 100 cells per 𝛍𝐋 and living in poverty 
Characteristic Number who Died (%) Relative Risk 
(95% CI)* 
P-value† 
Transition Clinic 
Attendance 
6/14 (42.9) 1.0 >0.99 
Non-Attender 3/7 (42.9) (.35-2.9)  
 
CD4+ T-lymphocyte count > 100 cells and not living in poverty 
Characteristic Number who Died (%) Relative Risk 
(95% CI)* 
P-value† 
Transition Clinic 
Attendance 
0/5 (0) 0 >0.99 
Non-Attender 0/10 (0)    (0-?)  
 Adjusted 
Mantel-Haenszel   
Relative Risk 
(95% CI)* 
P-value† 
---- ---- 
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Summary statement:   
Transition to adult HIV care may lead to poorer health outcomes, but few studies have 
examined the effect of transition and programs to improve post-transition outcomes. This 
study of transitioned perinatally HIV-infected young adults provides information about 
post-transition engagement in adult HIV care and assesses the effectiveness of a 
transition program. 
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ABSTRACT 
Purpose: To examine changes in HIV care engagement post-transition and identify 
associated factors. 
Methods:  We conducted a longitudinal, retrospective cohort study of perinatally HIV-
infected patients who transitioned from a pediatric clinic in the Southeastern US to adult 
HIV care between January 2003 and September 2012.  We assessed differences in the 
number of kept appointments and visit constancy (at least one quarterly visit) in 3 years 
(one year pre-transition and two years post-transition). We examined associations 
between clinical and sociodemographic characteristics, including exposure to transition 
program activities, and frequent care engagement in the first year post-transition. 
Stratified analysis controlled for confounding.  
Results:  Of 31 eligible and consenting participants, we could obtain medical records of 
25 participants for both the last pre-transition and first post-transition years. Participants 
kept over twice as many appointments in the last pre-transition year than the first post-
transition year (Median = 5, IQR 4-6 versus Median = 2, IQR 1-10; P=.002).  In the first 
year post-transition, the proportion of poorly engaged participants increased from one out 
of 30 (3%) in pediatric to nine out of 26 (35%) in adult HIV care (P= .006), while the 
proportion of frequently engaged participants decreased from 24 out of 30 (80%) in 
pediatric to eight out of 26 (30%) in adult HIV care (P<.001). No significant changes 
were observed between the first and second post-transition year. Patients who were 
African-American or Haitian (19%) or low-income (8%) were less likely to have kept 
frequent appointments than others (80%, P=.04; 50%, P=.06, respectively) in the first 
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year post-transition.  Engagement in adult HIV care was not significantly associated with 
participation in a clinic transition program.  
Conclusions: Care engagement decreased after transition to adult HIV care. Effective 
interventions to support transition to welcoming, high-quality adult HIV services are 
urgently needed.  
INTRODUCTION 
Advances in HIV care and treatment, specifically the introduction of combined 
antiretroviral therapy (ART), have greatly increased life-expectancy of children HIV-
infected in early life.1 As the prognosis has improved, an increasing number of 
perinatally HIV-infected (PHIV) children will “age out” of pediatric or adolescent care 
and transition to adult care services.2  Concerns have arisen about whether therapeutic 
successes of earlier decades will continue to benefit PHIV young adults after transition.3 
Continuous care is essential for all patients on ART as even short lapses in treatment may 
have significant consequences for viral suppression, drug resistance, and HIV 
transmission.4 Successful transition to adult care services may be more critical for PHIV 
patients. Many will be in advanced stages of HIV-disease having longer and more 
complex medical histories than their behaviorally infected counterparts, leading to 
complicated treatment and limited therapy options.5  
Transition experiences and outcomes are context-dependent and may vary 
according to policies and health systems.6 In the US, transition may be particularly 
challenging, in part because of fundamental differences between pediatric and adult 
medical care settings.7,8  In general, most pediatric patients have longstanding 
relationships with their  HIV provider and receive comprehensive “one-stop shopping” 
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medical and psychosocial services in a welcoming and familiar  environment. In contrast, 
adult care services tend to be less accommodating and more impersonal, requiring 
patients to independently navigate health and social services and self-manage their 
chronic conditions. PHIV young adults may not have the functional autonomy presumed 
in adult HIV care.9 PHIV children in the US are disproportionally members of ethnic 
minority groups living in underserved urban areas, burdened by psychosocial issues, 
including poverty and HIV stigma, which may further complicate transition.10 These 
issues may be exacerbated by the complexity of the US healthcare system,11 and the 
under-resourced, stressed system of HIV care for patients who depend on public health 
insurance.12  
To date, most transition studies have been qualitative and described barriers to 
transition from the perspectives of pre-transition youth, their caregivers and providers.13  
The few studies of young adults post-transition found considerable challenges and barriers 
to accessing adult HIV care and supportive services.14,15 A recent retrospective study of 
transitioned patients with behavioral and perinatally-acquired HIV concluded that the 
health care transition process needs to be optimized as only 50% of patients were retained 
in adult HIV care one year post-transition, and had completed at least two clinical visits.16  
Cross-sectional studies documented poorer health outcomes in patients in adult HIV care 
compared to their peers in pediatric care,17,18 and to HIV-infected adult patients.19  A recent 
study reported prolonged poor engagement in adult HIV care extending from adolescence 
through young adulthood (25-34 years old).20  Loss-to-follow-up among HIV-infected 
youth was found to be associated with receiving care at adult clinical settings.21  
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Acknowledging the risk of poor transition outcomes, transition services and 
programs are increasingly recognized as key components of pediatric or adolescent care.3,22   
Although many clinics have implemented programs to prepare and support transition in  
PHIV young adults,  few empirical data exist to guide these programs.13,23 This study  
assessed engagement in HIV care one and two years after PHIV patients transitioned from 
a comprehensive pediatric treatment program in the Southeastern US to adult care, 
exploring the role of various factors, including exposure to a transition program, in post-
transition engagement in care.   
METHODS 
We conducted a longitudinal retrospective study of patients who had transitioned 
to adult medical care from a university-based pediatric HIV clinic in the southeastern 
United States. The clinic provides outpatient comprehensive services to low-income and 
underserved children, adolescents and young adults through 24 years in age who acquired 
HIV early in life, nearly all through vertical transmission. Since 2008, the clinic has 
implemented a comprehensive transition program, largely supported by Ryan White 
funding. Available interventions included support from medical and psychosocial staff, 
educational workshops, support groups, peer and individual counseling, attendance of a 
transition clinic and follow-up by a transition social worker in the first year post-
transition. The transition clinic is a collaborative effort between pediatric and adult 
services to address post-transition attrition.24 To bridge the gap between pediatric and 
adult care, pediatric patients could be referred to an adult provider for one or more 
quarterly appointments, which were held at the pediatric clinic site in the last pre-
transition year. In the first year post-transition, transitioned patients could schedule 
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appointments with the now familiar adult provider at the academic center’s adult HIV 
clinic, who allots more than the traditional 15-minutes for a routine medical visit. In the 
second year post-transition, no transition services were provided.   
Participants  
Patients were eligible for study participation if they had transitioned from the 
pediatric clinic to adult medical HIV care settings between January 2003 and September 
2012. Living patients were excluded from study participation if they were unable to 
provide valid informed consent in person because of severe cognitive disability (as 
determined by staff psychologists during routine neuropsychological testing while in 
pediatric HIV care), incarceration, or relocation. Because we collected follow-up 
information for at least one year after transition, patients who died within one year of 
their transition date were also excluded.  
Procedures 
Approval for the study protocol was granted by the institutional review boards of 
relevant institutions. Former patients were contacted by phone or in person, as many 
maintained contact with pediatric clinic staff or their peers. Those interested in 
participating provided written informed consent at the clinic, and authorized disclosure 
and use of health information for study purposes. Consent was obtained by a researcher 
who had not been involved in the participants’ previous care.  After providing informed 
consent, participants completed a computer-assisted (Qualtrics) questionnaire about their 
transition experiences.  Sociodemographic and clinical data were abstracted from 
patients’ medical and social records using an abstraction form, without personal 
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identifiers. Sociodemographic information was reviewed and validated by the transition 
coordinator.  
Participants were recruited from September 2013 to February 2014. Data 
collection was completed on April 30, 2014. Study participants received $20 and were 
reimbursed for travel and parking costs. All participants were offered support from 
pediatric staff to re-engage in adult medical or social services, if needed and desired. 
Measures  
The primary outcome variable was engagement in medical HIV care, defined by 
the number of kept appointments. Participants’ last medical visit at the pediatric clinic 
was recorded as the transition date. For all participants, the number of kept medical visits 
as recorded in medical records was abstracted for at least two observation periods: 12 
months before the patient’s transition date, and 12 months post-transition. Depending on 
transition date and patient status, we also captured the number of medical visits in the 
second year in adult HIV care. Research suggested using multiple retention 
measurements.25 We measured engagement in HIV care as: (1) the number of kept visits 
during a 12-month observation period, and (2) “visit constancy” (proportions of 
participants attending at least one primary care visit at 3-month [quarterly] intervals in a 
12-month [four quarters] observation period). Patients were categorized as having had at 
least one kept visit with an HIV provider in 4,3,2,1 or 0 quarters. We measured visit 
constancy, because retaining HIV-infected patients in care at regular intervals results in 
better health outcomes.26 The 3-month interval is based on pediatric clinic practices 
where patients were scheduled to see their HIV provider quarterly for a routine 
appointment,22 which reduces the risk of exhausting the supply of anti-retrovirals (usually 
 
 
68 
 
prescribed for three months) and facilitates early detection of emergence of resistance. To 
assess factors associated with frequent care engagement in the first year post-transition, 
we assigned patients to two groups: regularly engaged (kept at least one medical 
appointment in each of the 3 or 4 quarters) and not regularly engaged (did not keep at 
least one appointment in each 3 or 4 quarters).  
Transition Program Effectiveness  
To assess the effects of the transition program, we examined if exposure to the 
comprehensive transition program (transitioned in 2008 or thereafter) and attendance of 
the pre- and/or post-transition clinic (at least one kept appointment) were associated with 
regular care engagement in the first year post-transition (at least one kept appointment in 
three or four quarters).  Information about transition clinic attendance was derived from 
data abstracted from medical records. Participants reported their satisfaction with the 
transition clinic in a computer-based survey. Systematic records of follow-up contacts 
with the pediatric transition social worker in the first year post-transition were not kept.  
Patient Characteristics 
Collected clinical and sociodemographic information included the most recent 
information before transition to adult medical care. Study participants’ pediatric medical 
and social records were reviewed to abstract the following information:  primary care 
history (including: transition date, age and CD4 count, viral load); demographic data 
(including: gender, HIV transmission category, race/ethnicity, educational attainment, 
household income, housing and employment status, type of health insurance), and 
psychosocial resources (including: relationship and family status).  Mental health and 
substance use information was incomplete and not included.  
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 Analysis  
Analysis was performed using Epi Info 3.5.4 (Atlanta, GA, 2012). Univariate 
statistics (medians, interquartile range [IQR], and mode) were used to describe 
characteristics of the study population. The Kruskal-Wallis test for two groups, which has 
no assumption of normality, was used to compare numbers of kept HIV appointments and 
assess significance of differences between the three observation periods (pre-transition, 
and one-and two-years post-transition). Outcome variables and covariates were 
dichotomized for inferential statistical analysis.  Significance testing for categorical 
variables was conducted using the Fisher exact two-tailed test (alpha=0.05). Stratified 
analysis was conducted to control for confounding. Prevalence ratios (crude and Mantel-
Haenszel adjusted RRs) were calculated to assess the strength of associations; the 95% 
confidence interval (CIs) interval was calculated to assess precision of estimates.   
RESULTS 
Between January 2003, and September 2012, 51 patients transitioned from the 
pediatric clinic to adult medical HIV care settings. Of these, nine patients (18%) were not 
eligible for study participation because of cognitive impairment (3), incarceration (1), or 
relocation (5). Nine patients (18%) were deceased when data collection was completed; 
five died within one year of care transfer and were not included in this study; four were 
included. Of the 33 eligible patients who were alive at time of data collection, 27 (82%) 
agreed to participate. Reasons for refusal were not ascertained. The total study population 
consisted of 31 patients (including 27 who agreed to participate and four who died after 
the first post-transition year).   
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All study participants were members of racial or ethnic minority populations, 
including African-Americans/Haitians (84%) or Hispanics (16%) [Table 4.1]. Nearly half 
lived in extreme poverty, with household incomes equal to or below the federal poverty 
level. At transition, most participants had completed high school or had passed the 
General Education Development (GED) test, were employed, and housed.  All but one 
had health insurance, and most relied on public insurance or Ryan White to cover their 
health care costs.  The last available CD4 count at the pediatric clinic showed severe 
immunosuppression (CD4 count < 200 cells/mm³) in over one-third of the study 
population. The median CD4 count was 333 cells/ mm³ (range 7-831 cells/ mm³).  
Median viral load was 1,613 copies/ml (range 28-238,581 copies/ml).  
Most participants had transitioned at age 24; 22 out of 31(71%) participants 
transitioned in 2008 or thereafter, when the comprehensive transition program was 
implemented. Sixteen (52%) study participants had ever attended the transition clinic; 
most (63%) had attended both the pre-and post-transition clinic. Of 13 attendants alive at 
the time of data collection, less than half (47%) reported they felt the transition clinic had 
been “very” or “quite” helpful to transition successfully.  
The median number of kept HIV, specialty-care, appointments decreased 
significantly in the first year in adult HIV care (Table 4.2). Participants kept more than 
twice as many appointments in the last year in pediatric care as in the first year post-
transition (median=5, interquartile range (IQR) = 4-6 appointments versus median = 2, 
IQR = 1-10 appointments; P=.002). The median number of appointments increased in the 
second year post-transition, but this increase was not significant. Trends were similar for 
visit constancy (Table 4.3). The proportion of poorly engaged participants significantly 
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increased from 3% in pediatric care to 35% in the first year post-transition (P=.006), 
while the proportion of regularly engaged participants significantly decreased from 80% 
in pediatric care to 30% in the first year post-transition (P <.001).  No significant changes 
were observed between the first and second year post-transition.  
The likelihood of regular engagement in the first year post-transition did not vary 
significantly by relationship status, educational achievement, employment status, housing 
arrangements, type of insurance, or health status (Table 4.4).  However, non-Hispanic 
black participants or those who lived in extreme poverty at transition were considerably 
less likely to be engaged in regular HIV care (P=.04, P=.06, respectively).  These 
associations were also observed in the last pre-transition year at the pediatric clinic, but 
there, the differences did not approach statistical significance (P=.38; P=.65, 
respectively). Participants who transitioned in or after 2008 were only slightly more 
likely to be regularly engaged in adult health care compared to those who transitioned 
before 2008 (33% versus 20.0%, respectively; P=>.99).  Overall, participants who 
attended the transition clinic were less likely to see their HIV provider regularly one year 
post-transition. However, participants living in extreme poverty were significantly more 
likely to have attended the transition clinic (10/12 [83%) versus 5/14 [36%]; RR=2.3; 
95% C.I. = 1.1-4.9, P=.04). When controlled for household income, the association 
between transition clinic attendance and less likelihood of regular appointment 
attendance no longer approached statistically significance (Supplemental Table 4.5).  
DISCUSSION 
To our knowledge, this is the first report that compared pre-and post-transition 
engagement in HIV care in a cohort of transitioned PHIV young adults. Both indicators - 
 
 
72 
 
frequency of kept appointments and visit constancy- showed that engagement 
deteriorated post-transition. Participants saw their HIV provider significantly less 
frequently and less regularly in the first year post-transition compared to the last year in 
pediatric care.  Of particular concern was the increase in the proportion of study 
participants, from 1 out of 30 (3%) in pediatric care to 9 out of 26 (35%) one year post-
transition, who dropped out of care altogether or only had seen an adult provider in one 
quarter. We did not observe any significant improvements in the second year post-
transition, which might have suggested that patients needed time to adjust but eventually 
would learn how to successfully navigate adult HIV care. The first year post-transition 
seemed crucial to establish care-engagement behavior for the transitioned PHIV young 
adults in our study. Similarly, a recent health care transition study of patients with 
behavioral-and perinatally- acquired HIV suggested that retention in adult HIV care in 
the first year post-transition may be a reliable marker of durable transition success.16 
Retention studies among diverse US populations of HIV-infected adults also have 
documented high attrition rates in the first year of enrollment in adult HIV care.27  
Participants who were African-American or Haitian, or who lived in extreme poverty, 
were less likely to be frequently engaged in adult HIV care in the first year post-transition 
compared to Hispanic participants and those with higher incomes, consistent with 
findings of other US studies.20,28,29  
This study did not provide evidence for the effectiveness of the pediatric clinic’s 
transition program to ensure a continuous transition. There is some evidence that 
interventions for other chronically ill youth (primarily youth with diabetes), including 
attendance at a transition clinic, meeting adult providers pre-transition and educational 
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activities, increased appointment attendance and satisfaction.30  In our study, 
economically vulnerable participants were significantly more likely to attend the 
transition clinic. Identification of patients in highest need for enhanced transition support 
could be a well-founded policy decision when resources are limited, especially when a 
comprehensive program available to all is implemented on a systemic level. However, 
both exposure to the comprehensive program and transition clinic attendance were not 
associated with greater likelihood of consistent appointment attendance, one year post-
transition. 
Lack of transition program success may be partially explained by a “type III 
error”: failing to detect program effectiveness because of problems in program design and 
implementation.31  Participant satisfaction among transition clinic attendants was 
relatively low, and over one-third only had visited the pre-or post-transition clinic. A 
“dose-response” relationship may have been operating; the transition clinic may have 
been of more help if attended more frequently. The data, however, suggest that transition 
clinic attendance was not only unassociated with significant improvement in engagement 
in care, but was actually associated with somewhat lower engagement in adult care. It, 
therefore, appears that lack of program success was related to failure to address important 
determinants of care-engagement behavior on different influential levels.32  Engagement 
in adult HIV medical care results from the complex interplay of factors at individual, 
social, community (including healthcare system) and policy levels.27 A mixed-methods 
study of transition experiences of the same study participants concluded that experiences 
in adult HIV care were characterized by the often times unmet need for patient-centered 
care, with convenient, accessible services and a personal, caring relationship with adult 
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providers.33  Study findings suggested that transition programs should include system-
level interventions to improve access and delivery of adult services to better facilitate 
transitioned patients, and recommended the use of a multi-level theory (socio-ecological 
theory) and a systematic planning model to inform program development, 
implementation, and evaluation.32  
Study participants were more frequently and regularly engaged in pediatric than 
adult HIV care, which seems to support the effectiveness of the pediatric clinic’s 
comprehensive care services to retain patients in care. The comprehensive pediatric HIV 
care model was developed to address the challenges of meeting the complex medical and 
psychosocial needs of HIV-infected patients.34 Possibly, the comprehensive coordinated 
primary care and psychosocial pediatric clinic services,  the long-standing relationship 
with pediatric providers, and clinic operations, including easy access, may have 
compensated for some of the effects of social marginalization, poverty and HIV-
infection.35-37  As PHIV young adults have complex medical and social needs, co-located 
and integrated adult medical and social adult services more similar to the pediatric model 
may be needed to prevent barriers or gaps in service delivery.38  
Our findings are preliminary; limitations include the small sample size and 
reduced power to detect statistically significant differences. Because this study was 
conducted at a single-site among PHIV young adults, findings might not be applicable to 
other settings and to behaviorally HIV-infected young adults.  Our (mediator) outcome 
measurement was restricted to engagement in HIV care, which is a pre-requisite for HIV 
care, but may not be always translate to desirable health outcomes, specifically viral 
suppression. Finally, program evaluation was planned and conducted about five years 
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after the comprehensive transition program was implemented.  Measurable objectives 
were not established during planning, and opportunities to systematically monitor 
program implementation were missed.   
  Despite these limitations, our study assessed key indicators at one- and two-years 
post-transition, showing that engagement in care declined post-transition. Poor retention 
and sub-optimal engagement in adult HIV care is a correctable cause of poor post-
transition health outcomes and disparities.  Sufficiently funded, sustained, and well-
planned strategies are needed to prepare PHIV adolescents and young adults for transition 
and keep them engaged in care post-transition.  Care-engagement behavior seemed to be 
established in the first year post-transition, suggesting that this is a critical year for 
establishing engagement patterns. This study suggests that differences in health care 
delivery systems in pediatric versus adult HIV services impacts post-transition care, 
indicating the need for much less fragmented, comprehensive adult care. Given the high 
risk associated with poor post-transition outcomes, it is essential that promising, well-
planned models be developed, fully implemented, and systematically evaluated to try to 
approximate in adult HIV care the comprehensive approach seen in pediatric care. 
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Table 4.1. Study population: Sociodemographic and clinical characteristics 
at time of transition to adult HIV care (N=31) 
 
Characteristic 
 
N (%) 
Male gender 15 (48) 
Race/Ethnicity 
      African American 
      Haitian 
      Hispanic 
 
14 (45) 
12 (39) 
 5 (16) 
HIV-1 acquisition 
      Mother-to-child 
      Blood products 
      Sexual (abuse) 
 
29 (94) 
 1  (3) 
 1  (3) 
Married/in relationship  14 (45) 
Completed high school/General Education Development test (GED)  27 (87) 
Employed (full or part-time) 20 (65) 
Household income  
      Equal or below Federal  Poverty Level (FPL) 
      101-200% of FPL 
      201-300% of FPL 
      301-400% of FPL        
 
15 (48) 
 9 (29) 
 5 (16) 
 2 (7) 
Housing 
      Unstable, moved around 
      With (extended) family 
      Own or shared  
 
  1 (3) 
14 (45) 
16 (52) 
Health Insurance 
       Medicaid 
       Ryan White 
       Medicare 
       Private 
       No insurance  
 
20 (65) 
  7 (23) 
  1 (3) 
  2 (7) 
  1 (3) 
CD4 T-cell count (cells/mm³)  
      < 200 
      200-499 
      ≥ 500 
 
12 (39) 
  8 (26) 
11 (36) 
Viral load (copies per ml) 
       <40 
       40-1000 
        ≥ 1000 
 
    
1    (3) 
14 (45) 
16 (52) 
 
Age (years) at transition  
      Mean (SD) 
      Median 
      Mode 
 
23 (SD 1.7) 
24 (18–26) 
24 
Transitioned after 1/1/08 (exposed to comprehensive transition 
program)  
22 (71) 
Attended transition clinic 16 (52)  
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Table 4.2. Number of kept HIV appointments: 
 pre-transition, one- and two years post-transition 
 
Period N Median Number 
of Scheduled 
Appointments Kept 
(Interquartile Range) 
Median 
Difference 
(Interquartile 
Range) 
P3 
Pre-transition (Pediatrics) 
One Year Post-Transition 
251 5.0 (4.0- 6.0) 
 2.0 (1.0-10.0) 
3.0 
(0-4.0) 
.002 
One Year Post-Transition 
Two Years Post-Transition 
202 2.0 (1.0-4.0) 
3.0 (1.0-4.0) 
1.0 
(-1.0-1.0) 
.78 
 
1Thirty medical records were obtained from pediatric and 26 from adult clinics with information on visits 
during the first post-transition year; records from 25 patients were obtained for both pediatric and adult 
clinics. 
2Of the 25 adult clinic medical records with information from the first post-transition year, three belonged 
to patients who transferred less than two years post-transition, and one patient died. Matched records were 
available for 20 participants.    
3From Kruskal Wallis test for two groups   
 
Table 4.3. Visit constancy (at least one quarterly kept appointment):  
pre-transition, one- and two years post-transition 
 
Number of 
quarters in which 
participant kept 
at least one  
appointment 
Last year in 
Pediatric 
clinic  
n= 30  
First 
year 
post-
transition 
n= 26 
p-value* Second year 
post-transition 
n= 21 
p-value † 
 0 or 1 quarter   1 (3) 9 (35) .006 8 (38) >.99 
2 quarters 5 (17) 9 (35) .21 5 (24) .63 
3 or 4 quarters 24 (80)  8 (30) <.001 8 (38) .83 
Total  100% 100%  100%  
 
*Fisher exact two-tailed p-value, comparing last year in pediatrics to first year post-transition 
†Fisher exact two-tailed p-value, comparing first year post-transition to second year post-transition 
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Table 4.4. Factors associated with regular engagement in adult HIV care,                    
1st year post-transition (n=26)¹ 
 
 
 
 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                  
 
¹ Of participants, we were able to locate 26 medical records one-year post-transition  
² Fishers exact two tailed test (P= .05) 
 
 
  
Characteristic at time of transition   n Regular: ≥1 kept 
appointment in 3 
or 4 quarters n (%) 
P-value² 
Male  
yes 
no 
 
14 
12 
 
2 (14) 
6 (50)  
 
.12 
 
 
Non-Hispanic black 
yes 
no 
 
21 
5 
 
4 (19)  
4 (80)  
.04 
 
Married/in relationship 
yes 
no 
 
14 
12 
 
6 (43)  
2 (17)  
.31 
 
Completed  high school/GED  
yes 
no 
 
4 
22 
 
1 (25)  
7 (32)  
>.99 
 
 
Employed 
yes 
no 
 
16 
10 
 
6 (38)  
2 (20)  
.62 
  
Household income below FPL 
yes 
no 
 
12 
14 
 
1 (8)   
7 (50)  
.06 
 
 
Lived with extended family 
yes 
no 
 
10 
16 
 
4 (40)  
4 (25)  
.70 
Medicaid insured 
yes 
no 
 
18 
8 
 
7 (39) 
1 (13)  
.38 
 
CD4 T-cell count <200 (cells/mm³) 
yes 
no 
 
9 
17 
 
2 (22)  
6 (35)  
.83 
 
Viral load  
≥ 1000 copies/ml 
< 1000 copies/ml 
 
14 
12 
 
2 (14) 
6 (50) 
.12 
 
Transitioned after 1/1/2008 
yes 
No 
 
21 
5 
 
7 (33)  
1 (20)  
>.99 
 
Attended transition clinic 
yes 
no 
 
15 
11 
 
2 (13) 
6 (55) 
.07 
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Supplemental Table 4.5. Association of transition clinic attendance with regular 
engagement in care in 1st year post-transition, controlled for poverty. 
Living in Poverty (household income ≤ Federal Poverty Level) 
Characteristic at Time of 
Transition 
n Frequent: ≥1 kept 
appointment in 3 or 4 
quarters n (%) 
P-value1 
Attended transition clinic 
Yes 
No 
 
10 
2 
 
1 (10) 
                     0 
 
>.99 
 
Not living in Poverty (household income > Federal Poverty Level) 
Characteristic at Time of 
Transition 
n Frequent: ≥1 kept 
appointment in 3 or 4 
quarters n (%) 
P-value1 
Attended transition clinic 
Yes 
No 
 
5 
9 
 
1  (20) 
 6  (67) 
 
.27 
      95% C.I.)   P  
Crude Prevalence Ratio     .24  (.06-.99)   .07 
Adjusted Prevalence Ratio  .38  (.07-2.1)   .39 
 
1 Fisher exact two tailed test (p=.05)  
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ABSTRACT 
We conducted a mixed-methods study of perinatally HIV-infected young adults 25-34 
years of age, who had transitioned from a pediatric clinic in Florida to adult settings. 
Participants completed a computer-assisted survey about pre- and post-transition 
experiences, satisfaction with transition program activities, demographics, and health 
status. Information was supplemented with debriefing notes and medical record 
abstraction. Data of 27 participants were analyzed using quantitative and qualitative 
(thematic analysis) methods. While most of 27 study participants had received transition 
services, 16 (59%) had trouble “doing well” in adult HIV care, nine (33%) had not seen 
an HIV provider in the past six months, eight (30%) felt they were currently in poor 
health, and 13 (48%) reported numerous unmet service needs in the past year. Transition 
was experienced as a loss of emotional and practical support. Needs for convenient, 
accessible adult HIV services and a personal, caring, relationships with adult providers 
characterized post-transition experiences.  Programs should transcend individual-level 
interventions to prepare patients for transition, and include interpersonal (expand social 
networks and mutual support) and system-level interventions (improve access to and 
delivery of quality adult services) to facilitate transitioned patients.    
Key words: health care transition, HIV, perinatally HIV-infected, transition programs  
INTRODUCTION 
Combination antiretroviral therapies transformed HIV infection from a 
progressive, fatal disease to a manageable chronic condition.1 As the prognosis for HIV 
infection greatly improved, most perinatally HIV-infected (PHIV) children who were not 
expected to survive, are now adolescents or young adults.2 These long-term survivors 
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continue to be pioneers as they “age out” of pediatric or adolescent services and transition 
to adult HIV-care settings.  
A smooth transition between these fundamentally different systems of care 
delivery is critical to achieving continued beneficial health outcomes, and purposeful 
transition is considered to be a key component in continuing care.3 However, as is the 
case with other chronic diseases, the development of theory-based transition programs 
has not kept up with medical advances which have increased survival.4  The growing 
body of transition literature for youth with chronic diseases has only just begun to 
describe youth with HIV-infection.5 Despite strong agreement for the importance of a 
purposeful, planned transition, limited data and little consensus exists as to which 
transition services are needed and which strategies are most effective.6,7  
Successful transition programs should be based on the young adult’s needs.4 
Transition expectations and concerns of HIV-infected adolescents and young adults, their 
caregivers, and providers have been the subject of several prospective qualitative 
studies.8-10 Although these studies provide critical insights, a full understanding of the 
issues and program implications must include the experiences of transitioned young 
adults, as patients who still receive pediatric care may have a limited understanding of 
upcoming challenges and expectations.4 
Earlier, Wiener and colleagues11 reported on the experiences of youth with HIV 
infection, most perinatally acquired, who transitioned from a large pediatric treatment 
and research facility to adult HIV care in 23 different states and the District of Columbia. 
This first study to report transition experiences and outcomes of PHIV young adults 
elucidated concerns about the complexity of transition and potentially adverse health 
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consequences of unsuccessful transition and interrupted HIV care, and reiterated the need 
for adequate transition preparation. Because transition experiences and outcomes are 
impacted by the health system and social context,12 we conducted a study of PHIV young 
adults who transitioned from a pediatric HIV clinic and then, for the most part, continued 
to obtain adult care in the same community. This study is a part of a larger research 
project to assess post-transition mortality and engagement in adult HIV care in PHIV 
young adults, and was conducted to assist in the interpretation of the quantitative findings 
of these studies and to formulate program recommendations based on transitioned 
participants experiences and needs.13 Our purpose was to describe exposure to and 
satisfaction with the transition program, pre- and post-transition experiences, and 
program recommendations in order to contribute to the development of effective, theory-
based transition programs.  
Context 
This study was conducted in Florida, a southern US state with a very high 
HIV/AIDS burden.14 Access to adult HIV care and services may pose difficulties as many 
of our patients are covered under public health insurance programs (e.g. Medicaid) which 
exposes them to gaps in insurance coverage.15 Patients are eligible for Medicaid 
insurance until age 18, after which they may no longer qualify or may experience lapses 
in coverage.  Due to the Florida gubernatorial decision not to implement Medicaid 
expansion, many low-income adults continue to have limited options for health coverage, 
even after the implementation of the 2010 Affordable Care Act.16  Medicaid enrollment 
and reimbursement in Florida is lower than the national average17 and falls short in 
supporting comprehensive HIV care.18  Ryan White programs for uninsured or 
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underinsured patients are inadequately funded to address the needs of the increasing 
number of patients with HIV-infection who have complex medical and social needs.19 
Consequently, the safety net of clinics and hospitals that serves the underinsured 
population in Florida has been stretched in recent years.  
All study participants had transitioned from a university-based pediatric HIV 
clinic in Miami-Dade County, Florida; a county with the highest poverty rates in Florida 
and with the highest HIV prevalence in the US.14,20 The pediatric clinic provides multi-
disciplinary, family-centered healthcare services to low-income and underserved 
children, adolescents and young adults up to age 24 who acquired HIV early in life, 
nearly all through vertical transmission. Comprehensive transition services were funded 
and implemented in 2008. The transition programs aims to prepare and support patients 
to independently navigate adult HIV services. Available services include program 
components to: (1) prepare patients for independent living (including: educational and 
psycho-social support, assistance to access housing and employment services, financial 
assistance and medical insurance); (2) address the lack of continuity between pediatric 
and adult HIV care (including: discussion of a transition plan, provision of linkage to 
adult services, and a transition clinic to temporarily bridge pediatric and adult care), and 
(3) increase patients’ self-management skills (including “life skills” training, support 
groups, and one year post-transition follow-up by a transition social worker to teach 
patients to solve problems encountered in adult HIV care).  In the “transition clinic”21,22 
patients could be seen by an adult provider in the pediatric clinic one year pre-transition.  
In the first year post-transition, transitioned patients could schedule appointments with 
the now familiar adult provider at the academic center’s adult HIV clinic, who allots 
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more than the traditional 15-minutes for a routine medical visit. In the second year post-
transition, no transition services were provided.   
In a small study previously conducted at the pediatric clinic, patients and their 
families expressed concerns about transitioning to the nearby adult immunology clinic, 
because of its size, higher caseloads of adult physicians, and fewer available services.8  
The university-based adult HIV clinic is located at the county’s public hospital through a 
contract with the medical school. The clinic serves approximately 2,800 HIV-infected 
patients, and funding for supportive or ancillary services is limited.  Consequently, young 
adults who transitioned may not receive the education and support they were accustomed 
to in the pediatric clinic, including: follow-up in case of missed appointments; counseling 
and home delivery services to support medication adherence; mental health services; 
assistance with housing, transportation and completion of insurance paper work, and 
other supportive services.   
METHODS 
Participants and Recruitment 
Permission for this study was granted by the Human Subjects Committee of the 
Institutional Review Board of appropriate institutions. Former patients were eligible for 
participation if they had transitioned from the pediatric HIV clinic to adult care settings 
between January 2003 and September 2012. Exclusion criteria were:  (1) substantial 
cognitive disability, as formerly established by staff psychologists at the pediatric clinic; 
(2) incarceration, or (3) relocation. 
 Because experiences of patients who successfully transitioned may differ from 
those who did not,5 we used several recruitment methods to maximize enrollment. 
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Eligible patients were contacted by the pediatric program coordinator to introduce the 
study. If up-to-date contact information was unavailable, we asked study participants to 
inform their peers about the study. If interested, the study lead author, who did not have 
any prior involvement with potential study participants, followed up to provide additional 
study information and set up an appointment to review and obtain informed consent and 
participants’ permission to abstract de-identified information from medical and social 
records. Study recruitment began in September 2013 and was completed in February 
2014. Study participants received $20 in cash and reimbursement for travel and parking 
costs, and were offered support from pediatric staff to access adult medical or social 
services, if needed and desired.  
Study Design and Data Collection 
This study used both quantitative and qualitative research methods to capitalize 
on the strengths of a mixed methods approach.23 Study participants completed a 
computer-assisted survey (Qualtrics), with open-ended and close-ended questions, 
supplemented with demographic and clinical information, obtained from patient’s 
medical records using a standardized abstraction form. The survey was conducted on-site 
at the pediatric clinic.  
Demographic information, including age, gender, race/ethnicity, educational level, 
household income below or above poverty level [$24,250 for a four-person household in 
2015],24 and transition date were abstracted from participant’s pediatric records. To 
assess current circumstances, we asked participants to answer questions about housing, 
family, and (any) employment, as well as gaps in medical insurance in the past 12 
months.  A measure of food insecurity, “In the past year, were you ever worried whether 
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food would run out before you got money to buy more?” was used as a proxy measure of 
current poverty.25 Data to assess engagement in adult HIV care were abstracted from the 
adult medical record. Based on current HIV/AIDS performance measures, the expectation 
for medical HIV care was at least one kept medical visit in the past 6 months.26    
Questions to describe transition experiences and recommendations for future 
programs were based on a semi-structured telephone transition questionnaire, developed 
by Wiener and colleagues.11 Because this study used a computer-assisted survey to 
collect study data, we could ask additional, detailed, questions about transition 
preparation, experiences in adult HIV care, and unmet service needs. We asked both 
quantitative (Likert scale) and qualitative questions (e.g. “could you please explain why”) 
to examine how well participants felt prepared for transition, and to assess exposure to 
and satisfaction with the pediatrics clinics transition program activities. This included 
discussion of their transition plan, attendance at support groups and transition clinic, and 
personal and clinical support received. We also asked participants to rate and explain how 
easy or difficult it was for them “to doing well” in adult HIV care. Additionally, we 
assessed usage and unmet needs of supportive and additional medical services in the past 
12 months, including use of a Ryan White case manager, help with emotional and 
financial problems, housing, employment or education, child care services, as well as 
usage and needs for specialty services, including gynecology, dental and nutrition.  
Debriefing after survey completion was offered to allow participants to further elaborate 
on their answers. Participant quotes were written down verbatim and debriefing notes 
were recorded in writing immediately after debriefing.  
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Analysis  
Quantitative analysis, conducted with SPSS 21, included univariate analysis to 
present descriptive information, followed by bivariate analyses. Covariates were 
dichotomized for inferential statistical analysis. Fisher’s exact two-tail test (alpha< 0.10) 
was used to determine whether differences in categorical variables with few observations 
were statistically significant.  
Qualitative information was systematically analyzed using the thematic analysis 
method; an iterative process followed to remain true to participant’s description while 
developing more abstract concepts in various stages of data analysis.27 Analysis was 
conducted manually, and included the following steps: familiarization with data and 
repeatedly reading texts, generating of initial codes, grouping of codes by various themes, 
and refinement and consideration of the meaning within and across themes. Initial coding 
was conducted by two researchers; in the final, exploratory phase, the analysis was 
discussed with a third researcher to explore associations between core concepts and 
themes, established literature, and theoretical perspectives related to transition 
experiences of PHIV young adults.  
Data Validation Strategies  
Pre-testing, informal respondent validation, and peer review were used to ensure 
adequacy and plausibility of the qualitative data.  First, the survey instrument was 
pretested with six clinic patients who would transition within one year. Based on their 
recommendations, we revised questions which were unclear and added open-ended 
questions to provide participants more opportunities to “tell their stories.” Second, after 
survey completion, we asked participants if any questions were unclear and if they 
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wished to clarify or elaborate, in order to enable them to correct potential 
misunderstandings and add information they believed was important. Hand- recorded 
verbatim quotes were validated with the participant. Third, to minimize pre-conceived 
notions and potentially expand alternative explanations, we conducted multiple coding by 
two different researchers. Both researchers had HIV-related research experience, but not 
with PHIV adolescents or young adults. To further minimize researcher bias, a third 
researcher, who had former clinical and research experience with PHIV adolescents and 
young adults but had not been involved in the study design or data collection, reviewed 
the analytic framework and data interpretation.  
RESULTS 
Between January 2003 and September 2012, 51 patients transferred from the 
pediatric clinic to an adult medical HIV-care setting. Of these, nine patients (18%) had 
died when data collection was completed, and nine more (18%) were ineligible for study 
participation because of cognitive impairments (n=3); incarceration (n=1), or relocation 
(n=5). Of the 33 eligible patients, one patient was lost to follow-up; five patients refused 
or did not return phone calls, and 27 (82%) agreed to participate.  Reasons for non-
participation were not ascertained. 
Quantitative data  
At time of study enrollment, participants were between 25-34 years of age 
(Mean=27 years); most had transitioned from the pediatric clinic to adult HIV care at 24 
years of age (Table 5.1). All participants were members of a racial or ethnic minority 
group, primarily African-American, most had completed high school or GED 
requirements, were currently housed, and had some type of employment. Fourteen out of 
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27 (52%) currently lived independently from their families or caregivers, were in a steady 
relationship, and had dependent children. At the time of study participation, 12 (44%) had 
experienced food insecurity in the past 12 months. About one-third of participants 
recounted a gap in their medical insurance coverage, had not kept an appointment with 
their adult HIV provider in the past 6 months, and felt they currently were in poor health. 
Participants who had not seen an HIV provider in the last 6 months, were more likely to 
assess their health as “poor” (5/8 [63%] versus 4/19 [21%] in “good” or “excellent” 
health; P= .07), and to report gaps in health insurance coverage in the past 12 months (5/8 
[63%] versus 4/18 [22%] no gaps in health insurance coverage; P=.08).  
Participants’ transition experiences were mixed.  Fifteen out of 27 (56%) 
participants remembered that transition was “easy” or “very easy,” although 11 (41%) 
reported that transition had been more difficult than expected.  Most participants (23 out 
of 27) recalled that someone had discussed a transition plan with them.  Participants 
reported that medical providers and pediatric clinic staff were most helpful in preparing 
them for transition, compared to family members and peers (Table 5.2).  Appreciation of 
transition clinic attendance was rated relatively low compared to participation in support 
groups: 8/17 [47 %] versus 6/8 [75%] of participants rated the intervention as “helpful,” 
respectively.  
Overall, 6 out of 10 participants reported it had been difficult for them to do well 
in adult HIV care, and many had problems post-transition (Table 5.3). Almost half of 
participants (14 out of 27) experienced a multitude (three to seven) of unmet needs for 
supportive and ancillary medical services in the past 12 months. Most frequently 
mentioned unmet needs were: support with finances, employment and education, and 
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dental and nutritional services. Participants who reported a multitude of unmet needs 
were more likely to have not completed high school/GED requirements (3/3[100%] non-
completion versus 10/24 [42%] completion; P=.10), and to report a gap in health 
insurance coverage in the past 12 months (6/8 [75%] versus 6/18 [33%] no gap in health 
insurance; P=.09).  
After transition, 19 participants had stayed in contact with the pediatric clinic. Of 
the eight participants who did not, six thought they should have remained in contact. 
Only two participants reported they had not needed any help from pediatric staff post-
transition. 
Qualitative data  
We identified themes in the following major categories: (1) transition 
experiences, (2) experiences in adult HIV care, and (3) recommendations for transition 
programs.   
1. Transition experiences 
The overarching theme was “loss;” as represented in three sub-themes:  (1) loss of 
long-term, close relationships with pediatric staff; (2) loss of “quality” services, and (3) 
loss of familiar, known, care. As previously noted, transition experiences were mixed. 
However, none of the participants described benefits associated with transition to adult 
HIV care.   
Loss of close relationships with the pediatric team  
When participants were asked to explain why transition was difficult or easy for 
them, many referred to the long-term, close relationships they had with their pediatric 
team, which transcended professional, patient-physician relationships. As one participant 
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described, “You [are] practically raised here. They have become like family to you” 
(Hispanic male, transitioned 8 years ago). Similarly, another participant replied : “I was 
very comfortable in the pediatrics because the doctor basically raised me from when I 
was a little girl and they was the only doctor I know that was there every step of the way” 
(African-American female, transitioned 2 years ago).  Several participants referred to 
strong emotional bonds with pediatric staff.  One participant wrote: “I was very attached 
to everyone, like the other patients, the doctors, the social workers and everyone else who 
was part of the team” (African-American female, transitioned 10 years ago), while 
another simply stated “I love it there” (African-American male, transitioned 1 year ago).  
Transition had been difficult not only because it was “difficult to let go of family” 
(Hispanic male, transitioned 8 years ago), but also because it would be difficult “finding 
people that care the way peds [pediatric clinic] treats you. I do not have any family 
except for him [his son]. I found some type of family here” (African-American male, 
transitioned 3 years ago). Another participant wrote: “Now I’m basically alone but I 
guess I am getting older” (Haitian male, transitioned 1 year ago). The importance of 
personal support was also expressed by a participant who felt transition was easy, 
“Because of the support system I had with my family” (Hispanic female, transitioned 1 
year ago).   
Loss of “quality” services 
In addition, participants referred to the loss of easy accessible services and 
tangible support of the pediatric team to explain difficulties with transitioning.  One 
participant briefly stated: “Pediatrics provided the best service” (African-American 
female, transitioned 3 years ago), while another remarked: “I was used to getting VIP 
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treatment and everything was handed to me, but now things have changed a lot” (Haitian 
male, transitioned 1 year ago).  Differences in required autonomy between pediatric and 
adult HIV care were also recognized by others. For example, one participant explained 
difficulties with transition as follows: “They (Pediatric staff) are here for you. They help 
us a lot more” (African American male, transitioned 1 year ago), while another 
participant wrote:  “Everything was much more simple and easier for me” (African-
American female, transitioned 10 years ago).  
Loss of familiar care.  
While a few participants reported that transition had been easy because they 
already had met the adult HIV provider or were receiving adult (specialty) care services, 
others reported that transition was difficult because they were unsure of what to expect. 
For example, one participant wrote:  “It was difficult to imagine what it would be like 
somewhere else and how their services would be compared the one received since 
pediatric care” (Hispanic female, transitioned 1 year ago). More specific concerns were 
expressed by others. While one participant was worried about the adult clinic 
environment “I was not ready for that world and how other people got the disease” 
(Haitian female, transitioned 8 years ago), others recalled concerns regarding the quality 
of the relationship with their adult provider.  For example, one participant wrote: “Will 
the doctor listen to me was a major concern as well” (African-American female, 
transitioned 3 years ago). Another said: “I had to get used to someone which is very hard 
to me because I have to trust someone with my information” (African-American female, 
transitioned 4 years ago).  
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In contrast, some participants may have engaged in avoidance coping and 
reported they had not believed that adult HIV care would be different. As one participant 
explained in the de-briefing: “They [pediatric staff] tell you that you will be on your own 
but you do not really listen” (African-American male, transitioned 2 years ago). 
Similarly, another participant said: “I did not take it too seriously. I really did not think it 
would be so different. I figured it would be much easier than they told me. Until it hits 
you… I was not coping too much. It’s like going from high school to college” (African-
American male, transitioned 3 years ago).   
2. Experiences in adult HIV care 
As noted previously, six out of 10 participants felt it was difficult for them to do 
well in adult HIV care. Two primary themes became apparent: (1) access to adult HIV 
care, and (2) the relationship with the adult HIV provider. In both, the perception of 
“being cared for” seemed to be important.  
Access to HIV care: Need for accessible and convenient services 
All participants reported they had experienced problems accessing adult HIV 
care. Most were “straightforward” access problems, including problems making 
appointments, getting urgent care questions answered, and difficulties with obtaining and 
keeping health insurance coverage. For example, participants reported they did not know 
“How to follow up on future appointments,” (Hispanic male, transitioned 2 years ago); 
or wrote: “I need help to remind me of when my appointment with the doctor is cause I 
tend to forget” (Haitian male, transitioned 2 years ago). Two participants, both currently 
not engaged in HIV care, described how inter-personal and system-related issues may be 
related. One participant wrote:  “Amazing doctor, took amazing care of me. Problem was 
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to get into her office to see her. They did not pick up the phone” (Hispanic male, 
transitioned 2 years ago).  Another reported similar experiences:  “She [adult physician] 
is a nice lady, it’s not her. It’s the system. It was the waiting and the trouble of making an 
appointment. Did not feel right over there” (African-American male, transitioned 2 years 
ago).   
Several participants reported that staff of the adult clinic had accommodated 
them. For example, one participant said:  “I did not know how to do it. Now they make 
them [appointments] for me” (African-American female, transitioned 4 years ago). 
Another participant wrote: “I can call him [physician] whenever, he calls me back, puts 
me on the list when I need to see him. He is personal” (African-American female, 
transitioned 10 years ago). The importance of easy access was also noted by participants 
who described problems with urgent care or walk-in appointments. As one participant 
worded it: “You leave a message with the nurse and when it is really urgent they call you 
back. I like my doctor, but I do not like the system” (Hispanic female, transitioned 4 
years ago).  Another participant commented: “In the adult clinic you were just a number. 
You cannot just show up”. After changing providers, he said: “You can just walk in and 
speak to someone who is there” (African-American male, transitioned 4 years ago).  
Finally, as noted previously, many participants had experienced difficulties with 
health insurance. In particular, public insurance was perceived to be complicated to 
navigate. For example, one participant wrote: “They [Medicaid insurance] made it very 
difficult for me to enroll again” (African-American male, transitioned 4 years ago), while 
another stated: “Ryan White is a nightmare over here. It’s much easier in Broward 
[adjacent county], I tell everyone to move” (Haitian female, transitioned 3 years ago).  
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Remarking on the advantages of private health insurance, another participant wrote: “It 
wasn’t too bad for me because I had private health insurance through my job and was 
able to choose a really good doctor. I have heard some of the experiences other people 
had and they were not good experiences so I am glad I was able to avoid that” (Haitian 
female, transitioned 3 years ago).   
Physician-patient relationship: Need for a personal, caring relationship 
Many participants described their perception of the relationship with a HIV 
provider and indicated the importance of a personal and caring relationship. For example, 
one participant stated, “Adult care is not personal” (African-American male, transitioned 
1 year ago), while another wrote:  “Most doctors I went to were very generic and cold. 
They lacked the connection and care I received since birth” (African-American female, 
transitioned 8 years ago). The strong feeling of “not being cared for” after transition was 
frequently mentioned. For example, one participant concluded: “Now we are adults, they 
do not care anymore” (African-American female, transitioned 3 years ago).   
Several participants explained why they believed a personal and caring 
relationship with the adult physician was important. One participant changed doctors a 
couple of times, until she found, “Someone who takes the time for me. AIDS is not just a 
disease, but it influences my whole life, everything. My doctor now understands that. He 
takes a lot of time for me and really wants to know how I am doing. He is interested in 
me” (Haitian female, transitioned 8 years ago). Others described how the physician-
patient relationship may impact how well patients take care of themselves. For example, 
one participant wrote “They stop caring. I think that’s why so many die. If you do not 
have the support of your family you get lost” (African-American male, transitioned 3 
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years ago). Several participants concurred. For instance, one participant stated: “They do 
not care for you in adult care. You just lose interest in that part of your life” (African-
American male, transitioned 3 years ago), while another said: “They just went through 
the motions. If they care, you will take better care of yourself also” (African-American 
female, transitioned 10 years ago). 
3. Recommendations for transition programs 
All participants offered recommendations for improving of the transition program. 
The following subcategories were developed (1) “Make it real,” (2) Match patient with 
HIV care that is responsive to their needs, and (3) Increase continuity between pediatric 
and adult care.  
As noted before, possibly with the exception of participants who had previous 
experience in adult (specialty) care, many observed they were aware that adult HIV care 
was “another world,” but had limited understanding of future expectations. Some 
participants seemed to manage uncertainty with avoidance coping, which may have led 
them to advise: “To listen and be focused on what they say. I did not want to believe it 
until it’s in front of me” (African-American male, transitioned 2 years ago), while others 
recommended “To make [patients] clear that things are going to change” (African-
American male, transitioned 3 years ago), and to “Keep reminding them” (Haitian 
female, transitioned 8 years ago). Limited understanding of future expectations in adult 
care settings may have led participants to recommend to: “Giving the patients the reality 
of the outcome” (African-American female, transitioned 10 years ago), or “Get them 
more prepared, like months ahead so they know exactly what’s going to happen when 
they actually get there” (African-American female, transitioned 4 years ago).  
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 Participants suggested that interventions include peer education or modeling or: 
“Having someone who has gotten through transition and be somewhat of a guide to 
others to let them know that it is possible to come out on the other side” (Hispanic 
female, transitioned 1 year ago). Others recommended that staff “Walk you through 
everything until one foot is inside the door” (Haitian male, transitioned 1 year ago).  
Another recommendation was to match transitioning patients with accommodating 
clinics, physicians and other providers. For example, as one participant recalled: “I 
should have gone to another clinic.… I would have done better. If you do not show up at 
[clinic name] they do not call you. At [clinic name] they call” (African-American male, 
transitioned 2 years ago).  Others advised to provide choices of adult providers to “Make 
sure the patient is with the best doctor that suits their needs” (African-American female, 
transitioned 10 years ago), or “Give a list of providers who can relate to young/working 
adults or college students.” (African-American female, transitioned 8 years ago).   
Participants suggested that more continuity between pediatric and adult care 
would be beneficial. As stated by one participant: “It’s very different especially coming 
from somewhere that does everything for you [and] all you have to do is show up” 
(Haitian female, transitioned 8 years ago), while someone else wrote :”They [insurance] 
send me papers but I never looked at them because they [Pediatric staff] were taking care 
of it. Now I have trouble and do not know how to do it” (African-American female, 
transitioned 2 years ago).  Increasing self-management of pediatric patients was, 
therefore, recommended. For example, one participant advised to: “Make sure they are 
willing to take their meds because u have no one to push or encourage you to take your 
medicine. It’s all up to u” (African-American male, transitioned 1 year ago). Meeting an 
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adult provider a couple of times before transition was suggested. As one participant                                       
explained: “The patient will feel comfortable and build a relationship with them before 
leaving” (Hispanic female, transitioned 4 years ago).   
Continued support of the pediatric team and follow-up after transition to adult 
HIV care was proposed.  As one participant stated: “Once you are out there you know 
how it is” (African-American male, transitioned 2 years ago). Recommendations 
included: follow-up by a pediatric social worker “To show them how to do things on their 
own” (African-American female, transitioned 10 years ago); support groups (African-
American male, transitioned 3 years ago), and “A few check- up calls throughout the 
year to see how the patient is doing” (Haitian female, transitioned 3 years ago).  Many 
also recommended continued assistance with medical insurance and provision of access 
to services post-transition.  
DISCUSSION 
Both quantitative and qualitative methods were used to describe the experiences 
of 27 PHIV young adults between 25-34 years of age, who transitioned from a pediatric 
clinic to adult HIV care in Miami-Dade County, Florida. HIV/AIDS disproportionally 
impacts already vulnerable populations;28 all study participants were members of a racial 
or ethnic minority group, primarily African-American, and most were low-income.  
Participants had transitioned from a pediatric clinic with comprehensive HIV services to 
adult HIV care settings with less or no ‘wrap around” services, in a community with a 
high HIV/AIDS burden and limited resources. In the few available studies of transitioned 
young adults, all participants were currently engaged in HIV care.5,11 In our study, nine 
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out of 27 participants (33%) did not have an appointment with an HIV provider in the 
past 6 months.  
Transition experiences, including loss of longstanding relationships with the 
pediatric team and loss of supportive services, were similar to those described in  
transition studies of youth with chronic diseases, including youth with HIV.8,11,29,30 In 
contrast, none of our participants described benefits of transitioning to adult HIV care, 
such as increased control and autonomy, suggested by others.5,9  Most participants 
recalled preparation for transition, had discussed a transition plan, and had received 
support from the pediatric clinic team for the transition process.  Nevertheless, 11 out of 
27 (41%) participants reported that transition was more difficult than expected; findings 
which were comparable with results reported previously.11  Transition preparation may 
have been hampered by avoidance coping, which was found to be a widely used strategy 
to cope with HIV infection in a study of HIV-infected adolescents.31 In addition, 
participants without prior adult care experience recalled that they had a limited 
understanding of future expectations in adult HIV care, as was observed in other studies 
of PHIV adolescents.9,32   
HIV-infected adolescents and young adults have been characterized as a ‘hidden 
population,’ due to their experiences with and fears of HIV/AIDS stigma.33 De Santis and 
colleagues31 described how social isolation starts at disclosure when PHIV adolescents 
are told to keep their HIV diagnosis secret, and is further reinforced by community 
stigma.  Although concealment of HIV status may be appropriate in an unsupportive 
environment, concealment also acts as barrier to social support, which includes emotional 
(empathy, caring), instrumental (provision of services), informational (advice or 
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suggestions), and appraisal (feedback for self-evaluation and affirmation) help through 
social interactions.34 The extent and nature of social support has been associated with 
health status and may influence the ability to remain in care.35,36 Explanatory mechanisms 
include modeling and reinforcement of desired behaviors, buffering of stress, and 
provision of access to resources.34 Previous studies of PHIV youth and health-care 
providers also suggested that HIV/AIDS stigma impacted both treatment and care 
transition, and reported disclosure concerns and anxieties about the adult clinic’s more 
diverse patient population.5,7,10,11 Our study suggests that the impact of HIV/AIDS may 
be more extensive. In particular, we were struck by feelings of loneliness and social 
isolation. After participants transitioned to adult HIV care, they lost the extensive social 
support of the pediatric team and their peers. As one participant expressed:  “Now I am 
an adult, I am basically alone.”  
In a concurrent retrospective, longitudinal study, we observed that participants 
were less frequent and less regular engaged in adult HIV care in the first post-transition 
year, compared to the last year in pediatric care.13  No significant changes were observed 
between the first and second post-transition year. Results of this study expand upon these 
findings.  Overall, 16 out of 27 (59%) participants reported it had been difficult for them 
to do well in adult HIV care, and many had experienced problems post-transition, 
including more difficulties taking meds as prescribed and more medical needs and 
complications. These results may not be surprising, as several studies have documented 
suboptimal clinical and retention outcomes among HIV-infected youth and young adults, 
but they are concerning.37-39 Successful transition is particularly important for PHIV 
young adults, as many may be in advanced stages of HIV-disease and have complex 
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medical histories, which complicates treatment and limits therapy options.40  Patients 
must keep frequent appointments and adhere to strict medication regimens, as poorly 
managed HIV infection will have adverse consequences for both personal and public 
health.41,42  Unmet needs for food, income or other essentials may have made it difficult 
for participants to prioritize their health care.43 Although supportive services are available 
in the community, many participants reported problems accessing these services post-
transition, and 14 out of 27 (52%) participants experienced a multitude of unmet needs 
for supportive and ancillary medical services in the past 12 months. Despite resource 
allocation for supportive services for low-income people with HIV-infection, barriers that 
prevent access and service utilization, including poor publicizing of available services, 
and systemic problems such as confusing systems, long wait lists and financial barriers, 
were documented among other HIV-infected patient populations.44  
Clearly, medical advances in HIV treatment will have little benefit without an 
understanding and improvement of systems responsible for attracting people to their 
services and retaining them in care.45 In our study, many participants reported it was 
difficult for them to do well in adult HIV care.  In general, research indicates that positive 
patient-care experiences are associated with greater adherence to recommended care, 
better clinical-care quality outcomes, and less health care utilization.46 In summary, many 
of our participants felt that the adult health care system fell short in meeting their needs. 
Participants reported having problems to access adult HIV care and perceived their 
relationship with an adult provider to be “impersonal.” Access problems included 
problems making, changing and remembering appointments, getting urgent care 
questions answered, and long wait times. Similarly, a study of patient experiences in 
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England found straightforward initial access elements (including the ability to get 
through on the telephone and problems to make appointments) to be most strongly related 
with quality of care.47   In addition, previous studies have documented difficulties with 
medical insurance as important transition barriers.5,7,10,11 Likewise, 11 out of 27 (41%)  
study participants reported problems with medical insurance after transition, while eight 
out of 27 (30%) reported a gap in medical coverage in the past 12 months. In our study, 
we observed an association between poor engagement in adult HIV care and gaps in 
medical insurance; other studies of HIV-infected adults reported an association between 
gaps in medical coverage and viral rebound and clinically significant resistance.48 
Financial barriers to regular HIV care are worrisome as they may impact both personal 
and public health. Participants’ problems with obtaining and keeping health insurance 
coverage post-transition warrant a further exploration of the accessibility of public 
insurance in our community.  
Different physician-patient relationships in adult care compared to pediatric care, 
with providers being more impersonal and disease-focused, seems to be a common, 
shared, experience among transitioned youth with chronic diseases, including HIV-
infection.5,11,29 Although some participants were very complimentary about the ‘personal’ 
relationship with their physician, others experienced a mismatch between their own and 
providers’ expectations.  In essence, participants expressed the need to be treated as a 
person and wanted their physician to care for them, while they felt their physician treated 
their symptoms and took care of them.  Patients’ needs for patient-centered care and an 
affective, supportive relationship with their medical provider should be sufficient 
justification to transform the patient-provider relationship. However, as also was 
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suggested by our study participants, the quality of the patient-provider relationship has 
been found to be associated with disease management and health outcomes.18   
Traditionally, transition programming has been the responsibility of pediatric and 
adolescent providers and little has been done by adult providers to ensure that the needs 
of transitioned patients are being met.49  Because of concerns that the adult clinic would 
require an autonomy level that pediatric patients may not possess, increasing self-
management skills to prepare young adults to independently navigate the health system 
became an important goal of transition programs for youth with chronic diseases.4  Or, as 
stated in the position paper  “Transitioning HIV-infected youth into adult health care” of 
the Academy of Pediatrics (2013):  
Seamless and successful transition from pediatric to adult-oriented care is 
dependent on these youth acquiring skills to allow them to be responsible for their 
management of their own health care. A well-planned transition enables youth to 
optimize their ability to assume adult roles and responsibilities.3(p193)  
Although enabling and empowering youth with HIV infection to self-manage 
their HIV disease is important for daily disease management, the emphasis on individual 
behavior also leads to a narrow-focus on changing the behavior of individuals, with 
limited attention for other factors that may inhibit or facilitate required behaviors. 
Consistent with the socio- ecological theory,50 participants experienced multi-level 
barriers in adult HIV care, including lack of social support (inter-personal), problems to 
access adult HIV care and supportive services, and impersonal relationships with adult 
providers. These barriers are influenced by community and macro-level (policy) 
influences, including HIV/AIDS stigma and the availability and allocation of resources 
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for HIV care for the poor. Consequently, multiple retention strategies appear to be 
necessary to effectively address barriers to adult HIV care.51   
Participant recommendations for improving transition programs reiterated 
suggestions in previous studies and position papers, including but not limited to: timely 
preparations, meeting adult providers pre-transition, and post-transition follow-up to 
provide assistance with medical insurance and access to services.3,52  Because transition 
from pediatric to adult care is guided by individual transition readiness and preparation, 
transition models and strategies focus on preparations at the individual-level. Given the 
social isolation of many PHIV young adults and the importance of social support for 
disease management, we suggest to transition patients in cohorts, instead of individually, 
and to develop (on site or and/or on-line) group-level interventions. Recently, a hospital 
in northern Thailand reported their experiences with preparing and transitioning patients 
in groups, which facilitated positive peer interactions and mutual support.53 In addition, 
with limited available resources, cost-effective group-level interventions allow clinic staff 
to address collective needs and establish networks for mutual assistance and on-going 
support. We recommend that these groups be continued post-transition, as patients may 
encounter problems in adult HIV care they did not anticipate and were not prepared for. 
These group-level interventions should be co-managed by members of both pediatric and 
adult teams. Planning models should be used to guide program development, 
implementation, and evaluation to contribute to the development of evidence-based 
transition programs.54   
There are limitations to the present study. First, this study was conducted among 
patients of a single pediatric clinic. Therefore, experiences of these patients may not be 
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reflective of those young adults with PHIV elsewhere. To allow readers to determine if 
study results have relevance for other clinical settings and patient populations, we 
provided detailed descriptions of our study population, study context, and findings.23 In 
addition, recall bias is possible because participants were asked to reflect on experiences 
that have occurred in the past.  Finally, qualitative studies are inherently concept and 
hypothesis generating and not confirming.  
Despite these limitations, this mixed-methods study of transitioned young adults 
with PHIV has important implications. First, future programs to prepare youth for 
transitioning should expand beyond programs to increase individual transition 
preparation to group-based interventions that build capacity of groups of PHIV young 
adults to cope collectively with transition to allow for mutual learning, empowerment, 
and on-going support. Ample resources should be made available for program planning, 
implementation, and timely evaluation to contribute to the development of evidence-
based transition programs. Second, a successful transition will not only depend on 
effective transition preparation, but also on the capacity of the adult health system to 
retain patients in optimal care. Our results highlight the need for continuing improvement 
in the delivery of HIV care and supportive services in south Florida, which will require 
dedicated resources and attention. In essence, our participants expressed the need for 
patient-centered care, which addresses patients’ needs for a personal relationship with 
their physician and convenient and accessible services.55 Because of the social, economic, 
and medical vulnerability of many PHIV young adults, we recommend to explore 
strategies to increase the continuity between pediatric and adult HIV care, including 
models to offer pediatric and adult HIV care at the same clinic site with shared 
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comprehensive services, or the creation of a network of adult HIV providers and social 
service organizations that are willing and able to “go that extra mile” to meet the needs of 
transitioned patients. Finally, resources should be mobilized to counter HIV/AIDS 
stigma, which continues to adversely affect the lives of people with HIV-infection.56  
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Table 5.1. Characteristics of study participants (N=27) 
Characteristics N (%) 
Race/ethnicity 
    African American/Haitian 
    Hispanic 
 
22 (87) 
  5 (13) 
  Gender 
     Female 
     Male  
 
14 (52) 
13 (48) 
  HIV transmission 
     Vertical 
     Transfusion 
     Sexual (abuse/child) 
 
25 (93) 
  1 (3) 
  1 (3) 
Age in years at transition  
     Mean (SD) 
     Median (range) 
     Mode  
 
23 (1.6) 
24 (18-25) 
24 
Years in adult HIV care 
     Mean (SD) 
     Median (range) 
     Mode 
 
 4 (2.8) 
 3 (1-10) 
 1 
 Foreign Born 
     Yes 
     No 
   
  5 (18.5) 
22 (81.5) 
Biological mother deceased (at time of transition) 
     Yes 
     No 
 
24 (89) 
  3 (11) 
Dependent children 
     Yes 
     No 
 
14 (52) 
13 (48) 
Completed GED/high school 
     Yes 
     No 
 
24 (89) 
  3 (11) 
Currently employment (full or part-time) 
     Yes 
     No  
 
17 (63) 
10 (37) 
Income at or below federal poverty line at transition 
     Yes 
      No 
 
11 (41) 
16 (59) 
Food insecurity past 12 months 
     Yes 
     No 
 
12 (44) 
15 (56) 
Current relationship status 
     Married/in relationship 
     Single 
 
14 (52) 
13 (48) 
Current living arrangements 
      Moving around/unstable 
      With (extended) family 
      Own/shared   
 
  3 (11) 
10 (37) 
14 (52) 
Health insurance gap past 12 months * 
      Yes 
       No  
 
  8 (30) 
18 (67) 
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Health status (self-report) 
     Excellent/good 
     Fair/poor 
 
19 (70) 
  8 (30) 
Engagement in HIV care past 6 months       
      At least one visit  
      No visit  
 
18 (67)  
  9 (33) 
*Missing one respondent reply 
 
Table 5.2. Who/what was helpful to prepare you for transition?  
Felt supported by: n (%) 
Medical providers 
    Very/quite helpful 
    Somewhat/not helpful 
 
23 (85) 
 4  (15) 
Staff of the pediatric clinic 
    Very/quite helpful 
    Unsure  
    Somewhat/not helpful 
 
11 (78) 
 3  (11) 
 3  (11) 
Parents/guardians or other family members 
    Very/quite helpful 
    No reply 
 
12 (44) 
15 (56) 
Peers from the pediatric clinic  
    Very/quite helpful 
    Unsure  
    Somewhat/not helpful 
 
10 (37) 
  4 (15) 
13 (48)  
Transition clinic attendance (n= 17) 
    Very/quite helpful 
    Unsure  
    Somewhat/not helpful 
 
 8 (47) 
 3 (18) 
 6 (35) 
Attendance of support groups (n= 8) 
    Very/quite helpful 
    Unsure  
    Somewhat/not helpful 
 
 6 (75) 
 1 (13) 
 1  (13) 
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Table 5.3. Experienced problems after transition to adult HIV care 
Problems post-transition n (%) 
It has been difficult for me to do well in adult HIV care 
    Yes  
    No 
 
16 (59) 
11 (41) 
More difficulties to take meds as prescribed  
    Yes  
    Maybe  
    No 
   
12 (44) 
  1 (4) 
14 (52) 
More medical needs or complications 
    Yes  
    Maybe  
    No 
 
11 (41) 
  1 (4) 
15 (56) 
Problems with medical insurance 
    Yes  
    Maybe  
    No 
 
11 (41) 
  2 (7) 
14 (48) 
Difficulties finding supportive services  
    Yes  
    Maybe  
    No 
 
10 (37) 
  3 (11) 
14 (52) 
Problems finding HIV provider  
    Yes  
    Maybe  
    No 
 
  8 (30) 
  1 (4) 
18 (67) 
Unmet service needs in the past 12 months  
     0 - 2 needs  
     3 - 7 needs            
 
 14 (52) 
 13 (48) 
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CHAPTER VI 
CONCLUSIONS AND PROGRAM RECOMMENDATIONS 
Transition from pediatric to adult HIV care may lead to poor health outcomes, but 
few studies have examined the effects of transition and programs to improve post-
transition outcomes. The purpose of the three studies comprising this dissertation was to 
assess health outcomes and experiences of PHIV young adults who had transitioned from 
a pediatric out-patient clinic in Miami-Dade County, Florida, to adult care settings 
between January 2003 and September 2012. The first two studies examined post-
transition health outcomes, including mortality and engagement in adult HIV care. While 
these studies provided valuable follow-up information on important health outcomes, 
they contributed little to the understanding of the experiences from the perspectives of 
transitioned young adults. The third study explored their experiences and 
recommendations for improvement of the transition program.   
The first study examined post-transition mortality and associated clinical and 
socio-demographic factors. Transition was associated with high mortality (18%), 
especially in patients who were severely immunosuppressed, unemployed or less 
educated at time of transition.  Most patients (56%) had died in the first year post-
transition. Because of the poor health status of deceased patient at transition, it is unclear 
whether transition had negatively impacted the disease course. Transition clinic 
participation was preferentially recommended to patients living in extreme poverty or 
with severe immunosuppression; when controlled for these factors, mortality risk was 
identical among transition clinic attenders and non-attenders, suggesting that this 
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intervention did not impact mortality.  We recommended that comprehensive programs 
focus on improvements in clinical care and include academic and employment services.   
 Continuous HIV care is essential, as even short lapses in care and treatment may 
have significant consequences for viral suppression, drug resistance, and HIV 
transmission. The second study examined a pre-requisite for HIV treatment - regular 
engagement in HIV care - and assessed if the transition program had achieved its goal of 
continuous care.  Multiple measurements, including the number of kept appointments and 
visit constancy, showed that engagement in HIV care significantly decreased post-
transition, especially among African American or Haitian and low-income participants. 
Compared to the last year in pediatric care, study participants were less frequently and 
less regularly engaged in adult HIV care in the first year post-transition. Particularly 
concerning was the significant increase in poorly engaged participants from 3% in 
pediatric to 35% in adult HIV care.  No significant changes were observed between the 
first and second year post-transition, suggesting that the first year post-transition was 
crucial to establishing a behavioral pattern.  The finding that study participants kept more 
(regular) HIV appointments in pediatric than adult care seemed to support the 
effectiveness of pediatric comprehensive services to retain their patients in care.  
Possibly, the comprehensive coordinated primary care and psychosocial pediatric clinic 
services, the long-standing relationship with pediatric providers, and clinic operations, 
including easy access, compensated for some of the effects of HIV-infection, social 
marginalization, and poverty experienced by PHIV young adults.   
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Engagement in adult HIV care was identical among participants and 
nonparticipants in the transition program.  Lack of transition program success may be 
partially explained by a “type III error”, that is a failure to detect program effectiveness 
because of problems in program design and implementation. As the transition program 
focused on influencing personal determinants and preparing patients for requirements of 
adult HIV care, environmental determinants that may inhibit engagement in adult care 
were inadequately addressed.   
Despite strong agreement of the importance of a purposeful, planned transition, 
limited data and little consensus exists as to which transition services are needed and 
which intervention strategies are most effective. Successful transition programs should be 
based on young adult’s experiences and needs, which were explored in the third study. 
While most participants had received a range of transition services in pediatric care, 
many said it was difficult for them do well in adult HIV care and reported a multitude of 
unmet service needs in the past 12 months.  Participants had experienced transition as a 
loss of (emotional and instrumental) support and familiar care. Exploratory analysis 
suggested that social and system-related determinants shaped individual transition 
experiences, including poverty (limited access to resources), HIV/AIDS stigma (limited 
social support), and system differences between pediatric and adult care (lack of 
continuity of care).  Consistent with socio-ecological theory, participants experienced 
multi-level barriers post-transition, including social isolation because of HIV/AIDS 
stigma, impersonal, “non-caring,” relationships with adult providers, and problems 
accessing adult HIV care.  
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Participants recommended continuation of assistance post-transition and 
expressed a need for patient-centered adult HIV care, which is designed to address 
patients’ need for a personal relationship with their physicians and considers their 
experiences with access, including convenience and easy accessibility of services. 
Because of the social isolation of many PHIV young adults and the importance of social 
support for disease management, we proposed to transition patients in cohorts, instead of 
individually, and develop group-level interventions to establish social networks and 
facilitate mutual, ongoing support.  Planning models should guide program development, 
implementation, and evaluation to contribute to the development of evidence-based 
transition programs. 
Some limitations and strengths of this research are important to note. This study 
was a single center study of a large pediatric clinic, which required fewer resources than a 
multi-center study and allowed for more involvement of pediatric clinic staff and 
collection of data potentially of relevance for the pediatric clinic’s program. However, a 
small scale, single-center study also carries the risk of recruiting too few participants to 
make meaningful comparisons and detect statistically significant differences.  Limitations 
of this study included the small sample size, non-eligibility and non-participation of 15 of 
51 patients, and limited generalizability of study results.  The first two studies were based 
on retrospective analyses of  pre-existing data available in medical and social patient 
records, which came with the risk of  missing information on potentially relevant factors 
not available in established datasets (including data on substance use and mental health), 
and with problems to assess temporal relationships. Participants transition experiences 
and recommendations, as described in the third study, may have been influenced by recall 
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bias. Their experiences are context dependent and may not be reflective of experiences of 
PHIV young adults elsewhere. An important study question was if the transition program 
affected transition outcomes. An experimental study design, in which study participants 
are randomized to intervention and control interventions, would have been superior to the 
observational design of this study. As little information was available regarding which 
specific program interventions were delivered to which participants, we were unable to 
assess and compare the differential effects of various components of the comprehensive 
transition program, with exception of the transition clinic intervention.  
 These studies have implications for the development of transition programs and 
for future research. First, although enabling and empowering youth with HIV infection to 
self-manage their disease is important for daily disease management, this approach may 
lead to a narrow focus on psychological attributes and individual behaviors, while 
system-level and structural barriers that may inhibit or facilitate required behaviors are 
ignored or inadequately addressed.  The notion that adequate transition preparation will 
lead to the successful transition of the autonomous patient with high self-efficacy seems 
to be normative and based on cultural beliefs and values instead on empirical evidence. 
Consistent with the findings of other studies, this research has shown that many socially 
and economically vulnerable PHIV young adults face insurmountable environmental 
barriers after they transitioned to adult HIV care.  A greater understanding and response 
to social determinants of health may pave the way to more successful transition 
programs.  
 In particular, this research suggested systemic problems in the accessibility and 
delivery of adult HIV care and supportive services to help HIV patients manage 
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competing challenges, address unmet psychosocial needs, and facilitate the successful 
management of HIV disease.  Our results highlighted the need for continuing 
improvement in the delivery of adult HIV care and supportive services in south Florida, 
which will require dedicated resources. While in the past decade resources for HIV/AIDS 
research focused on studies concerning adherence to ART medication, attention and 
resources should be devoted to the problem of poor engagement in care. Similar to newly 
diagnosed adults with HIV, our research findings indicated that the first year in adult HIV 
care is crucial to establish care engagement behavior in PHIV young adults.  
Interventions to improve retention should focus on the first year post-transition, with 
extra attention for those at highest risk of poor engagement, including African-American 
or Haitian patients and those living in extreme poverty.    
Second, study results suggested a need to re-examine current transition practices 
that prepare PHIV young adults individually for transition and transfer patients to adult 
care around their 25th birthday. While unintended, these practices may further isolate 
PHIV young adults with limited personal social support and who lose the support of the 
pediatric team and their peers from the clinic after they had transitioned. Because of the 
potential importance of social support in HIV management, this research suggested to 
prepare and transition patients in cohorts, instead of individually, and investigate 
interventions to establish mutual supportive networks.  
Third, program development is a complex process, and neglect in a particular 
phase may lead to mistakes and inadequate decisions in subsequent phases.  Without a 
full appraisal of the problems and possible solutions, interventions may address the 
wrong determinants or only address some of the influential determinants and, therefore, 
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will not have the desired effect. Notably, social determinants of health are intertwined. To 
understand what may play a role, we looked at single factors and their impact on health.  
However, public health programs need to use a much broader perspective to include all 
(modifiable) factors of importance.  Social-ecological theory provides a framework for 
assessment of multi-level influences. Planning models should be used to systematically 
develop, study, adopt and evaluate innovative strategies; prospective and multi-center 
studies are needed to bolster evidence, and ample resources should be made available to 
develop evidence-based transition programs.   
Finally, traditionally pediatric providers are responsible to prepare their patients 
for transition. As transition success is highly dependent on the capacity of adult services 
to facilitate transitioned patients, it is recommended that transition programs become a 
collaborative effort of pediatric and adult providers.  Participants were a crucial source of 
information in this research and successful programs should be based on their needs.  We 
suggest that PHIV young adults play a vital role in the development and implementation 
of transition programs. These programs should empower and support transitioning young 
adults to take responsibility for management of HIV disease and address structural 
constraints.   
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Office of Research Integrity  
Research Compliance, MARC 270  
    
   
  
MEMORANDUM   
  
  
To:     Dr. Consuelo Beck-Sague    
CC:  File   
From:    Maria Melendez-Vargas, MIBA, IRB Coordinator  
Date:    October 19, 2015   
Protocol Title:  "Transitioning HIV-infected young adults to adult clinical care"    
 
  
The Health Sciences  Institutional Review Board of Florida International University has 
re-approved your study for the use of human subjects via the Expedited Review process.  
Your study was found to be in compliance with this institution’s Federal Wide Assurance 
(00000060).  
  
IRB Protocol Approval  #:  IRB-14-0298   IRB Approval Date:  10/19/15  
TOPAZ Reference #:  102881  IRB Expiration Date: 10/15/16  
  
As a requirement of IRB Approval you are required to:  
  
1) Submit an IRB Amendment Form for all proposed additions or changes in the 
procedures involving human subjects.  All additions and changes must be reviewed and 
approved by the IRB prior to implementation.  
2) Promptly submit an IRB Event Report Form for every serious or unusual or 
unanticipated adverse event, problems with the rights or welfare of the human subjects, 
and/or deviations from the approved protocol.  
3) Utilize copies of the date stamped consent document(s) for obtaining consent from 
subjects (unless waived by the IRB).  Signed consent documents must be retained for 
at least three years after the completion of the study.  
4) Receive annual review and re-approval of your study prior to your IRB expiration 
date.  Submit the IRB Renewal Form at least 30 days in advance of the study’s 
expiration date.  
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5) Submit an IRB Project Completion Report Form when the study is finished or 
discontinued.  
  
Special Conditions:   N/A  
  
For further information, you may visit the IRB website at http://research.fiu.edu/irb.   
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ADULT CONSENT TO PARTICIPATE IN A RESEARCH STUDY  
Evaluation of MFCP’s transition program  
  
PURPOSE OF THE STUDY  
You are being asked to be in a research study.  The purpose of this study is to find out how 
former patients of Pediatrics or the Adolescent Clinic are doing after they have transitioned to 
adult medical care. Your information and experiences will help us to improve the transition 
program.  
NUMBER OF STUDY PARTICIPANTS  
If you decide to be in this study, you will be one of 120 people in this research study.  
DURATION OF THE STUDY  
Your participation will take at most 45 minutes.    
PROCEDURES   
The purpose of this consent form is to help you decide if you wish to be included in this research 
study.  Please read this form carefully. To be in a research study you must give your informed 
consent.   
“Informed consent” includes:  
• Reading this consent form,  
• Having the staff explain the research study 
to you,  
•  Asking questions about anything that is not 
clear.  
You should not join this study until all your questions are answered! If you sign this consent 
form you assure us that you understand what this study is about and that you voluntarily decide 
to participate.    
 We will get the information we need for this study in two different ways:  
1. We will use information about your past treatment history – CD4 count/percentage, HIV 
RNA viral load, medical and Emergency Department visit history, HIV-transmission risk 
factor, and diagnosis from your  medical records. From your psychosocial record, we will 
get demographic information (such as your gender, ethnicity, education, household 
income and employment). To permit your provider to release your private health 
information and to allow us to use your medical information for this study, we will need 
you to sign the HIPAA form.  
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2. We will ask you to answer a survey.  We will ask about your experiences with transition, 
what kind of problems you might have had, and how you are doing right now. You will 
answer the questions on a laptop computer at the Pediatrics office.      
RISKS AND/OR DISCOMFORTS  
You need to realize that there might be a small risk that people not authorized will find out you 
have participated in this study or will see the information you have provided. To limit these 
risks, we have agreed on ways to keep your information as safe as we possibly can. We will keep 
your records private and we will not ask you for your name or any other information which 
might identify you.     
BENEFITS  
One of the things we want to find out is whether you were able to get medical care and other 
services after transition.  Ana Garcia, Barbara Messick, or another MFCP staff member will help 
you if this is a problem for you. They will bring you in contact with services, if you wish.  Also, the 
reason we do this study is to improve the transition program, which will help patients who will 
transition in the future.   
ALTERNATIVES    
There are no known alternatives available to you other than not taking part in this study.     
CONFIDENTIALITY  
The records of this study will be kept private and will be protected to the fullest extent provided 
by law. In any sort of report we might publish, we will not include any information that will 
make it possible to identify you.  Research records will be stored securely and only the 
researcher team will have access to the records.  However, your records may be reviewed for 
audit purposes by authorized University or other agents who will be bound by the same 
provisions of confidentiality.  
    
To help us further protect your privacy, we are applying for a Certificate of Confidentiality from 
the National Institutes of Health. With this Certificate, the researchers cannot be forced to 
disclose information that may identify you, even by a court subpoena, in any federal, state, or 
local civil, criminal, administrative, legislative, or other proceedings. The researchers will use the 
Certificate to resist any demands for information that would identify you, except as explained 
below.  
You should understand that a Certificate of Confidentiality does not prevent you or a member of 
your family from voluntarily releasing information about yourself or your involvement in this 
research. If an insurer, employer, or other person obtains your written consent to receive 
research information, then the researchers may not use the Certificate to withhold that 
information.  
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The Certificate of Confidentiality does not prevent the researchers from disclosing voluntarily, 
without your consent, information that would identify you as a participant in the research 
project under the following circumstances: disclosure of child abuse, or intent to hurt self or 
others.  
 The U.S. Department of health and Human Services (DHHS) may request to review and obtain 
copies of your records.   
COMPENSATION & COSTS  
We will give you parking validation and pay for transportation costs you have made to come to 
MFCP’s office. If you decide to participate in this study, you will receive $20 in return for your 
time and effort. You will not be responsible for any costs to participate in this study.     
RIGHT TO DECLINE OR WITHDRAW  
Your participation in this study is voluntary.  You are free to participate in the study or decide to 
withdraw your consent, at any time.  Your decision will not affect any benefits to which you are 
otherwise entitled. We (the investigators) have the right to remove you without your consent at 
such time that we feel it is in the best interest.   
RESEARCHER CONTACT INFORMATION  
If you have any questions about the purpose, procedures, or any other issues relating to this 
study you may contact Susan Biersteker (principal investigator) at FIU. Susan’s phone number is: 
(305)494-8415. Susan’s e-mail is: susan.biersteker@yahoo.com.     
IRB CONTACT INFORMATION  
If you would like to talk with someone about your rights of being a subject in this research study 
or about ethical issues with this research study, you may contact the FIU Office of Research 
Integrity by phone at 305-348-2494 or by email at ori@fiu.edu.  
PARTICIPANT AGREEMENT  
I have read the information in this consent form and agree to participate in this study.  I have 
had a chance to ask any questions I have about this study, and they have been answered for me.  
I understand that I am entitled to a copy of this form after it has been read and signed.  
   ________________________________              __________________  
Signature of Participant           Date  
  
________________________________  
Printed Name of Participant  
  
________________________________       __________________  
Signature of Person Obtaining Consent       Date  
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Chart Abstraction Form Transition Study                                  
Participant # ______ Completed by: ______________ Date: _____________ 
Patient Status 
o   Deceased (complete chart abstraction form) 
 Date (month/year) of death: __________ 
   If deceased: AIDS-related causes   o yes   o no   o unknown 
o Reached and signed consent/HIPAA (complete chart abstraction form) 
o Not eligible because of low cognitive functioning (no chart abstraction) 
o Reached and no consent (no chart abstraction) 
o Moved outside of S.Florida (no chart abstraction) 
o Lost to follow-up (no chart abstraction) 
 
A.  Primary Care History 
1. Before transitioning, received care at: 
o Pediatric Immunology and Infectious Diseases  (Pediatric Immunology) 
o Adolescent Medicine’s Special Adolescent Clinic (SAC) 
 
2. Transferred to the pre-transition and/or transition clinic?  
o Only pre-transition clinic at Pediatric Immunology or SAC 
o Only post-transition clinic at UM/JMC 
o Both pre-transition and post-transition clinic 
o No 
o Unknown 
 
3. Last medical appointment at Pediatrics /SAC  
 Month/year of transition:   ___________________ 
 
4. Age last appointment at Pediatrics/SAC  _____  years/month 
  
5. Total time of treatment at Pediatrics/SAC? _____    years/months  
 
6. Transitioned to (adult HIV care):  
o Special Immunology Clinic  
o Obstetric and Gynecology’s Primary Care Clinic Jackson 
o Clinic (other than Jackson) 
o Community provider (ASO/CBO) 
o Private provider 
o Unknown 
 
B.  Socio-Demographics 
    7.   Year of birth: _____ 
 
    8. Gender 
o Male 
o Female 
o Transgender:  O male to female  O female to male 
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Participant # ______  
 
9.  Race/Ethnicity 
o Black or African American, please specify:  
   O Haitian       O Caribbean        O Other 
o   White/non-Hispanic 
o   Hispanic, please specify: 
  O Cuban   O Puerto Rican  O Mexican   O other 
o Other 
 
10.    Foreign born? 
o Yes 
o  No 
o  Unknown 
 
11.    HIV-transmission category 
o Perinatal 
o  Blood products 
o  Heterosexual 
o  MSM 
o  IDU 
o  Unknown 
 
12.     HIV status biological parents  
Mother:  O HIV+       O HIV- O unknown 
Father:    O HIV+      O HIV-               O unknown   
 
Mother deceased?  0 yes    O no     0 unknown 
 If yes, age of participant when mother died:    ___years 0 unknown 
  
13.   Highest level of education completed  
o Did not complete high school 
o High school diploma or equivalent  
o Vocational/tech program after high school  
o College or university (some) 
o Unknown 
 
14.   Household income 
o Equal or below poverty line 
o 101-200% of Federal poverty line 
o 201-300% of Federal poverty line 
o 301- 400% of Federal poverty line 
o ≥401%% of Federal poverty line 
o Unknown 
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Participant # ______  
 
15.    Employment (more than one answer category possible) 
o Employed  
o Unemployed, looking for work 
o Unemployed, disabled/not healthy enough to work 
o Enrolled in school 
o Other ________ 
o Unknown 
 
16.    Health insurance (more than one answer possible) 
o Yes, please specify:  
O Medicaid 
O Medicare 
O Ryan White   
O other public funding source (than Ryan White) 
O Private health insurance 
o Other _____________ 
o No 
o Unknown 
 
17.   Residence/neighborhood (during 12 months before transition, most of the time) 
o Zone IV (Liberty City& vicinity): 33147,33150,33138,33167, 33169, 33161) 
o Zone II (Opa-Locka, Carol City):  33055,33054,33169,33179,33162,33056,33180,33160  
o Zone V (Little Haiti, Brownsville, part of Liberty City):  33142,  33127, 33157  
o Zone VI (Little Havana, Overtown): 33125, 33135, 33145, 
 33136,33128,33130,33129,33132,33131,33109  
o Zone X (Homestead, Florida City):   33031,33032,33033,33039,33034,33035  
o Other 
o Unknown 
 
18.   Housing (during 12 months before transition, most of the time) 
o Homeless (in the street/outdoors/shelter) 
o Moved around  (temporarily in someone’s home) 
o Lived in own or shared place 
o Lived with family (f.e.: parent, guardian, grand parent, aunt/uncle, brother/sisters)  
o Other, please explain __________________________ 
o Unknown 
 
19.   Relationship status (at time of transition) 
o Married 
o In relationship, but not married 
o Single 
o Unknown 
 
 20.   Pregnant/children or took care of anyone’s children? 
o Yes 
o No (skip to 22) 
o Unknown (skip to 22) 
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Participant # ______  
 
21.   HIV status biological children 
o HIV positive 
o HIV negative 
o Children have different status 
o Unknown 
o N/a: does not have biological child 
 
C. Health Status (most recent information at transition). See also: q24 
22. History of diagnosed depression? 
o Yes 
o No 
o Unknown 
 
23.   Neurodevelopmental assessment  
Age of participant (m/y) when tests were conducted: _______ 
 
(1). Executive functioning (D-KEFS): 
Trails:    Score  ____   Qual. : ____________ 
Verbal Fluency:      Score ____    Qual.:  ____________ 
(2) Attention (CPT)  
Omissions:   Score ____    Qual. : ____________ 
Commissions:   Score ____    Qual.: ____________ 
HIT SE ISI Change:  Score ____    Qual.: ____________ 
(3) Memory (WMS-III or WMS-IV)  
Auditory Memory Index: Score ____    Qual.: ____________ 
Visual Memory Index: Score ____    Qual.: ____________ 
(4) Achievement/(reading (WJ-III) 
Passage comprehension:  Score ______ Grade Equivalent ___ 
(5) Intelligence (WAIS-IV or WASI). FSIQ:  _________________ 
 
24.    CD4 count, viral load and adherence to ART  
 Baseline: Pre-
transition. Last 
results at 
Pediatrics/SAC 
Post-transition: 1 
year after 
transition 
Post transition: 
 2 years after 
transition 
Post transition: most 
recent 
 information (i.e. 
currently) 
Clinical category 
 HIV disease 
staging 
  
 
  
CD4 count   
 
  
Viral load 
 
    
Non-compliance 
to ART? 
 
0 yes 
0 no 
0 unknown 
O ART not 
prescribed 
0 yes 
0 no 
0 unknown 
O ART not prescribed 
 
0 yes 
0 no 
0 unknown 
O ART not prescribed 
 
0 yes 
0 no 
0 unknown 
O ART not prescribed 
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Participant # ______  
 
25.  Number of made & kept appointments with HIV provider 
 
 1st quarter: 
1- 3 months 
Made      Kept 
2nd quarter: 
4-6 months 
Made      Kept 
3rd quarter: 
7-9 months 
Made      Kept 
 
4th quarter: 
10-12 months 
Made      Kept 
 
Baseline:  
Last 12 months 
at SAC/Pediatrics 
 
 
 
 
      
Follow-up:  
1 year post-
transition 
        
Follow-up: 
2 year post-
transition 
        
Follow-up: 
In the past 12 
months  
 
 
 
 
      
 
26.  Number of made & kept appointments with case manager 
  Made          Kept 
Baseline:  
last 12 months  at      
SAC/Pediatrics 
  
Follow-up:  
1 year post-transition 
 
 
 
Follow-up: 
2 year post-transition 
 
 
 
Follow-up: 
In the past 12 months  
 
 
 
 
 
27.   Total number of E.R. visits & hospital admissions 
        E.R.  Hospital 
Baseline:  
Last 12 months  at SAC/Pediatrics 
  
Follow-up:  
1 year post-transition 
 
 
 
Follow-up: 
2 year post-transition 
 
 
 
Follow-up: 
In the past 12 months  
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Participant # ______  
 
28. General remarks (do not include private information) 
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------- 
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